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Influenza A viruses (IAVs) continue to be a threat to human health. Despite extensive studies, the 
mechanisms underlying the IAVs-host interactions during IAV infection remain elusive. We employed 
quantitative proteomic methods to systematically explore the host cell protein expression responses to 
IAV infection and examine the function of a critical IAV protein called NS1 by identifying its host binding 
partners. Specifically, we used a 2-dimentional gel electrophoresis (2-DE) based proteomic method to 
screen host proteins whose expression was substantially altered by IAV. One critical protein named IκB 
kinase-gamma (IKKγ) was found to be significantly down-regulated during IAV infection. Functional 
studies indicated that IKKγ and IAVs were mutually inhibitory and IKKγ might be the target for virus to 
inhibit IFN production.   
IAV protein NS1 is known to play critical roles in viral pathogenesis and host immune responses. 
Through 2-DE proteomic approach and mass spectrometry, we identified several novel host cellular 
proteins that were associated with NS1. First, we found that heterogeneous nuclear ribonucleoprotein 
A2/B1 (hnRNP A2/B1) interacted with NS1, affected replication, transcription, expression and nucleo-
cytoplasmic translocation of NS1 mRNA, and the eventual whole virus replication. Second, two ATPase 
proteins, RUVBL1 and RUVBL2, were identified to associate with NS1 for regulation of cell apoptosis in 
the absence of IFNs. Third, based on previous finding of the interaction between a DEAD family protein 
designated as DDX100 and NS1 through a more sensitive proteomic approach called SILAC (stable 
isotope labeling with amino acids in cell culture), we found this interaction promoted virus replication 
through enhancing viral NS1 gene replication, transcription, and dsRNA unwinding.  
   In summary, through quantitative proteomic, molecular and cell biology studies, we generated the 
global picture of host cell protein expression responses to IAV infection. For IAV NS1, several host 
cellular proteins were found to interact with NS1 to regulate the host cell action and virus proliferation.  
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1. Seasonal, Pandemic Influenza, and Influenza Virus 
Influenza (flu) is a public health threat and causes a long-term economic burden. Since the beginning 
of the 20th century, there have been four flu pandemics: 1. 1918 Spanish flu killed approximately 50-100 
million people (Johnson and Mueller, 2002); 2. 1957 Asian flu was responsible for 70 thousand deaths; 3. 
1968 Hong Kong flu was much milder, but still caused about 40 thousand deaths (Poland et al., 2007); 4. 
2009 swine flu caused 8,829 infections with 74 deaths in 40 countries in the first month of infection 
(Garten et al., 2009). Additionally, other outbreaks of flu were significant, for example, the 1997 Hong 
Kong avian influenza, which was the first recorded avian influenza virus to break the species barrier with 
transmission to human beings, resulted in 358 deaths in 607 reported cases by July, 2012 (WHO, 2012). 
Besides the destructive pandemics, the seasonal flu circulates worldwide and causes annual epidemics 
with more than 200,000 hospitalizations and up to 49,000 deaths every year in the United States (CDC, 
2011). Variant virus strains cause seasonal flu outbreaks every year. Due to the influenza virus variance, 
people may not have specific antibodies to protect themselves from each type of strain. So CDC 
recommends that people are vaccinated with seasonal flu vaccines at the beginning of each flu season.    
The main transmission vehicle for influenza between humans is respiratory contents from coughs and 
sneezes. Flu symptoms include a sudden onset of high fever or chills, uncomfortable nose and throat, dry 
cough, headache, joint aches and some people, especially children may experience complications such 
as vomiting and diarrhea. The flu infection increases the possibility of other viral or bacterial infections, 




vaccines, in particularly for older and younger people, and those who are pregnant or have a chronic 
medical condition, since they are at higher risk of influenza infection and flu-related diseases.   
    Both seasonal and pandemic influenza are caused by influenza viruses, which are classified into three 
types: A, B and C. Influenza A viruses (IAVs) are the most virulent and can be further divided into 
different subtypes based on two influenza virus proteins: hemagglutinin (HA) and neuraminidase (NA). 
Seventeen H antigens (H1-H17) and nine N antigens (N1-N9) have been reported. IAV is a member of 
the family Orthomyxoviridae containing a single-stranded, negative sense, eight-segmented RNA genome 
encoding 11 proteins (Hale et al., 2008). The total genome size is 13,588 bases. HA gene encodes 
hemagglutinin, responsible for virus intracellular entry through binding sialic acid on the surface of 
epithelial cells. NA gene encodes neuraminidase, which assists newly formed virion release by catalyzing 
the hydrolysis of sialic acid residues. M gene encodes matrix proteins 1 and 2 (M1 and M2) mediated by 
RNA splicing, which are responsible for formation of viral coat and ion channel. NS gene encodes distinct 
non-structural proteins 1 and 2 (NS1 and NS2) mediated also by RNA splicing, responsible for 
counteracting host immune responses and blocking cellular mRNA nuclear export, etc. NP gene encodes 
nucleoprotein (NP) responsible for encapsulating the virus genome for viral RNA replication, transcription 
and packaging. PB1, PB2 and PA genes encode three subunits of viral RNA polymerase, which can 
associate with NP and viral RNA to form the viral ribonucleoproteins (vRNPs) as the viral core for virus 
genome replication, mRNA transcription and translation.  
The IAV replicative cycle starts as HA binds to sialic acid sugars on the surface of epithelial cells with 
the battlefield being in the nose, throat or lungs of mammals and intestines of birds. The sialic acid 




change to assist virus fusion with the cellular membranes (Carr and Kim, 1993). Once inside the cell, 
virus is disassembled by the acidic cellular environment. The vRNA molecules, accessory proteins and 
RNA polymerase are then released into the host cell cytoplasm (Lakadamyali et al., 2003) and migrate to 
the cell nucleus, where the vRNA can be replicated by RNA-dependent RNA polymerase through a 
transient complementary positive-sense RNA (cRNA) (Kash et al., 2006). The vRNA can be packaged as 
genome or processed to become mRNA, followed by nuclear-export to the cytoplasm for translation. 
Influenza viral HA and NA proteins are segregated immediately after synthesis by the ribosomes in the 
ER, further sorted in the Golgi complex and exclusively transported to apical plasma membranes via 
secretory vesicles. Other viral proteins are translated on free ribosomes, and then transported back to the 
nucleus to form new viral particles with negative-sense vRNA genome. NP and NS1 proteins bind to 
nascent RNAs to suppress viral RNA synthesis. HA and NA proteins budding from the Golgi cluster into a 
bulge in the cell membrane thereby prepare to coat viral particles, and then vRNA and viral core proteins 
enter this membrane protrusion with HA and NA to complete assembly and bud off through the plasma 
membrane. After the bridge between viral NA and sialic acid residues is cleaved, the mature virions will 
be released to infect neighboring cells. The influenza viral replicative cycle is shown in Fig. 1. 
IAV protein NS1 has been shown to play important roles in viral pathogenesis and host immune 
responses during IAV infection. These include: (i) modulation of viral RNA synthesis and viral mRNA 
splicing (Fortes et al., 1994); (ii) inhibition of cellular translation and RNA process but assisting viral 
mRNA translation (Aragon et al., 2000); (iii) regulation of virus particle morphogenesis (Garaigorta et al., 
2005); (iv) inhibition of apoptosis by activating phosphoinositide 3-kinase (PI3K) pathway (Ehrhardt et al., 




dependent viral pathogenesis; and (vi) inhibition of dendritic cell action (Fernandez-Sesma et al., 2006). 
The effect of NS1 on host cell apoptosis has been controversial. On one hand, NS1 has been reported to 
play a role in pro-apoptosis (Zhang et al., 2011). On the other hand, NS1 has been reported to bind to 
and activate PI3K and its effector AKT (Ehrhardt et al., 2007b), which subsequently phosphorylates and 
inactivates the pro-apoptotic factors (Igney and Krammer, 2002). 
The biggest challenge to eliminate influenza is the variance of virus strains resulting from frequent 
mutation. There are two ways for influenza virus to mutate: antigenic drift and antigenic shift. Antigenic 
drift is much more common and involves point mutations in the HA and NA genes. Since viral RNA 
polymerase lacks the RNA proofreading function, viral genome replication induces higher error rates. So 
the mutants frequently appear in viral genes. This mutation may cause the existing antibodies to fail to 
recognize the virus infection, so people have to be immunized with new influenza seasonal vaccines. 
Antigenic shift results from vRNA reassortment of two or more virus gene fragments. Antigenic shift may 
happen when more than one type of influenza virus strain infects one cell, and one strain can mistakenly 
coat another virus strain gene(s) like HA; then a new type of virus strain will be generated. This change is 
sudden, large and more destructive, since the new type of virus can not be counteracted by existing 
immunity. Consequently, the emergence of pandemics may be triggered if the new virus can spread 
easily from person to person in a sustained manner.   
There are two classes of commercial anti-flu drugs approved by the FDA (Jackson et al., 2011). The 
first class of drugs includes M2 inhibitors, amantadine and rimantadine, which can block ion channels 
formed by M2 and then inhibit the nucleo-cytoplasmic translocation of viral genome (Pinto and Lamb, 




recent virus strains, such as the 2009 pandemic A/H1N1 strain are resistant to M2 inhibitors (Garten et 
al., 2009). So this class of drug for influenza treatment is not highly recommended. The second class of 
anti-flu drugs includes NA inhibitors, oseltamivir and zanamivir. This class mainly functions in inhibiting 
the release of newly synthesized viruses from the infected cells by inhibiting NA enzymatic activity (Fig. 
2). NA inhibitor drugs are quite promising, especially as the only class of antiviral drug for human 
influenza virus treatment. Most influenza viruses are sensitive to this class of drugs, like novel pandemic 
A/H1N1, but the virus resistance to this class of anti-flu drugs is still evident during the flu season 
(Renaud et al., 2011). Another drawback of this class of drugs is that patients need to apply drugs as 
early after virus infection as possibly, but most patients can not recognize the flu infection at the 
beginning. So new anti-flu drug development is necessary to control the potential influenza pandemics 
and many new antiviral strategies are undergoing development, including targeting different viral or 
cellular proteins, interference with the virus-required critical interactions or boosting immune-modulating 
drugs.  
2. Type Ι IFN Responses 
Innate immune responses are the first line of defense for the host against pathogens, like bacteria 
and viruses. The responses triggered by the innate immune system are antigen-nonspecific and relatively 
short-term. Innate immune system can recognize “foreign” by targeting pathogens with distinguished 
characters, like virus double-stranded (ds) RNA, CpG and gram-negative bacterial wall LPS. Those 
unique characters from pathogens are called pathogen-associated molecular patterns (PAMPs), and 




recognizing PAMPs of the invading pathogen with consequence of defense initiation. One main function 
of the innate immune system is to secret cytokines to block pathogen invasion. As signaling molecules, 
cytokines are produced by many kinds of cells, especially by T-helper lymphocytes, and circulate to 
deliver the “message”. They are small, soluble and can bind to specific cytokine receptors. More than 80 
known cytokines are secreted by virus-infected cells, and the first secreted ones after the virus infection 
include type I IFNs, type II IFN (IFN-gamma), interleukin-6 (IL-6), IL-12, and tumor necrosis factor alpha 
(TNF-α). Type I IFNs (IFN α, β, ε, κ and ω) as multifunctional cytokines are essential for host innate 
immune responses to viruses, bacteria, protozoa, and cancer. Three main pathways can trigger the 
production of type I IFNs: RIG, TLR7 and TLR3/4 (Fig. 3). (i) Retinoic acid-inducible gene product I (RIG-
I) and melanoma differentiation-associated gene-5 (Mda-5) as two TLR-independent viral nucleic acid 
detectors can be activated by viral nucleic acids (Andrejeva et al., 2004). The binding of viral nuclei acid 
to the receptors activates IKK epsilon and TKK binding kinase 1 (TBK1), two serine/threonine kinases 
that phosphorylate and further promote IRF3 and IRF7 to transfer to the nucleus resulting in initiation of 
type I IFN transcription. (ii) TLR7 and TLR9 in endosomal compartments of plasmacytoid Dendritic Cells 
(pDCs) are responsible for recognition of ssRNA (Heil et al., 2004) and unmethylated CpG motifs (Hemmi 
et al., 2000) for type I IFN production. The activated TLR7 and TLR9 cause the adaptor myeloid 
differentiation primary-response protein 88 (MyD88) to recruit a protein complex consisting of IL-1 
receptor-associated kinase 1 (IRAK1), IRAK4, IRF7 and TNF receptor-associated factor 6 (TRAF6) (Krug 
et al., 2004). IRF7 is the predominant IRF activated protein early after pathogen infection in pDCs 
(Prakash et al., 2005) and becomes ubiquitinated by TRAF6 E3 ligase with consequence of IRF7 




TLR4 can identify viral dsRNA or bacterial LPS and transmit signal through TRIF adaptor protein and 
TRAF members (Yamamoto et al., 2002). After receptor interacting protein-1 (RIP1) is recruited (Wertz 
and Dixit, 2010), TRAF6 catalyzes the Lys63 polyubiquitination on itself. The activated TRAF6 in turn 
activates IκB kinase (IKK), which is composed by two catalytic IKK subunits (IKK-α and IKK-β) and one 
regulatory subunit (IKK-γ, also termed NEMO or IKBKG). The activated IKK further activates NF-κB 
through releasing its inhibitors (IκBs) and then activated NF-κB exposes its nuclear localization signal 
(NLS) to translocate to the nucleus to initiate the transcription of various genes, like type I IFNs.  
Type I IFNs bind to a common receptor consisting of IFNAR1 and IFNAR2 chains to regulate immune 
responses or cell activities (like apoptosis) through several downstream pathways. One pathway induced 
by type I IFNs is PI3K signaling pathway, which plays an important role in the IFN responses. PI3K 
contains catalytic subunits (p110 α, β, γ, and δ) and regulatory subunits (p85 α and β) (Guiducci et al., 
2008). The activated PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to generate 
phosphatidylinositol-3,4,5-triphosphate (PIP3), which further regulates an array of substrates, such as Akt 
or kinase 3′-phosphoinositide-dependent klinase 1 (PDK1)  through a pleckstrin-homology (PH) domain 
on substrates. The binding of Akt PH domain to PIP3 phosphorylates and activates Akt, which in turn 
activates its numerous substrates to modulate cell activities, like cell survival and growth. Taking pro-
apoptotic factors as an example, Bcl-2-associated death promoter (Bad) and Forkhead family member 
FKHR can be phosphorylated and inactivated by Akt to inhibit apoptosis (Datta et al., 1997; Fresno Vara 
et al., 2004). Other substrates, cAMP response element-binding protein (CREB) and IKK can also be 
phosphorylated by Akt to induce the activation of the Bcl 2 promoter, leading to up-regulation of Bcl 2 for 




proliferation and metabolism. For example, Akt phosphorylates p21 to inhibit its anti-proliferative effects 
through restricting it within the cytoplasm (Zhou et al., 2001); AS160 (Akt substrate of 160 kDa) can also 
be phosphorylated by Akt in response to insulin (Kane et al., 2002). AS160 is reported to play roles on 
cellular metabolism, like glucose translocation (Manning and Cantley, 2007). For effect of type I IFNs on 
anti-virus, type I IFNs promote virus-infected cells to be recognized by cytotoxic T cells or killed by NK 
cells, or promote cell apoptosis to limit virus replication.  
3. Apoptosis 
In order to respond to a wide range of stimuli like virus, cells induce cell-programmed death, called 
apoptosis. Apoptosis can be triggered by both internal and external signals, such as virus infection, heat, 
growth factors, or cytokines. The characteristic changes induced by apoptosis include chromosomal DNA 
fragmentation, chromosome condensation, membrane blebbing, and collapse of potential between 
outside and inside of mitochondrion. Two signal pathways in the receptor-activated apoptosis have been 
extensively studied: Fas-Fas ligand-mediated and TNF-induced pathways. Fas-induced apoptosis starts 
at the Fas ligand binding to Fas receptor, which processes to trimerizate, followed by recruiting adaptor 
molecules such as Fas-associating protein with death domain (FADD). The recruited FADD further 
collects procaspase 8 to the receptor complex for self-cleavage; and then caspase 8 is released and 
activated, which in turn activates Bcl-2 interacting protein (Bid) with consequence of cytochrome c release 
(Chawla-Sarkar et al., 2003). Release of cytochrome c by the mitochondria is a hallmark for apoptosis. In 
the cytoplasm, cytochrome c binds to apoptotic protease activating factor 1 (APAF1) to form apoptosome 




activated caspase 8 directly cleaves procaspase 3 to release and activate caspase 3 with consequence 
of the cleavage of DNA fragmentation factor 45 (DFF 45). The activation of DFF45 induces DFF40 to 
translocate to the nucleus, resulting in internucleosomal DNA fragmentation, as another hallmark of 
apoptosis.  
The second pathway is the TNF-induced pathway. TNF-α is secreted by activated T cells and 
macrophages in response to bacterial infection. The interaction between TNF-α and its receptor TNF-R1 
causes the receptor conformational change with consequence of recruiting the downstream molecules, 
like RIP1 and TRAF2. TRAF2 binds to cellular inhibitor of apoptosis 1 (cIAP1) to form TNF-R1 signaling 
complex. TRAF2 also ubiquitinates RIP1, resulting in IKK-gamma recruiting, followed by the activation of 
NF-κB. The activated NF-κB promotes the transcription of anti-apoptotic genes, like cFLIP (cellular FLICE 
inhibitory protein), cIAP-1, cIAP-2 and TRAF 1. Alternatively, after receptor activation, TRADD, RIP1 and 
TRAF2 dissociate from TNF-R1 and recruit FADD to cleave procaspase 8 to produce caspase 8 for 
apoptosis induction as mentioned above. NF-κB signals are central for the life and death of cells: if NF-κB 
signals are inhibited, the anti-apoptotic proteins are down-regulated, leading to cell death; if NF-κB 
signals are activated, anti-apoptotic proteins are up-regulated, resulting in cell survival. 
Besides receptor-based regulation of apoptosis, some factors, such as the Bcl-2 family, Bax family 
and IFNs, also utilize distinct pathways to regulate apoptosis. Type I and type II IFNs induce apoptosis in 
a wide range of cell lines. One mechanism by which IFN induces apoptosis is similar to the TNF-induced 
pathway as mentioned above (Thyrell et al., 2002; Xu et al., 1998). IFN strongly induces TRAIL and/or 
Fas/FasL to recruit and activate FADD, which in turn activates caspase 8. The activated caspase 8 further 




release as mentioned above. The IFN-induced apoptosis is important during the early stages of virus 
infection, since apoptosis suppresses virus replication through killing virus-infected cells. However, 
numerous viruses have evolved some mechanisms to counteract the IFNs-inducted apoptosis for the 
completion of, at least, the progeny virus replication. Vaccinia viral protein inhibits apoptosis mediated by 
Fas or TNF-α (Dobbelstein and Shenk, 1996). Adenovirus encodes one protein called E1B-19K to block 
apoptosis mediated by TNF (Teodoro and Branton, 1997). As mentioned above, one of IFN-induced 
pathway, PI3K pathway, results in apoptosis inhibition, and influenza virus NS1 protein was reported to 
inhibit apoptosis by binding PI3K (Ehrhardt et al., 2007a). Besides targeting downstream factors of IFNs, 
viruses also inhibit the secretion of IFNs for apoptosis inhibition. Hepatitis C virus (HCV) encodes viral 
nonstructural 5A protein to suppress the secretion of IFNs by inactivating PKR (Gale et al., 1997). 
Influenza virus NS1 protein also suppresses PKR activation by competitively binding to viral dsRNA 
(Wang et al., 2000).  
4. Objective of This Project 
There are two specific aims in the present study: First, to analyze the host-influenza virus interactions 
at the proteome level by examining the global protein expression alteration using quantitative proteomic 
methods. Second, to assess the role of NS1, a vital IAV protein, by identifying host cellular proteins that 
are associated with NS1; and to characterize the functions of the identified critical interactions between 
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Figure 1. The replicative cycle of influenza virus in host cell (modified from textbook) 











Figure 2. NA inhibitors suppress virion release (Moscona, 2005). NA inhibitors suppress NA 
enzymatic activity to hold new virions on the plasma membrane.  
  
 
Figure 3. Three main pathways induced by pathogen to trigger the production of type I IFN. The 
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    Blockage of the induction of type I interferons (IFNs) is essential for the success of influenza virus 
proliferation in host cells. Several molecular mechanisms by which influenza viruses inhibit IFN induction 
have been characterized. Here we report a potentially new strategy influenza viruses employ to inhibit 
IFN production during viral infection. Through a two-dimensional gel electrophoresis based proteomic 
approach, we found that the expression of IκB kinase-gamma (IKKγ) was suppressed by influenza A virus 
infection in human lung epithelial A549 cells. Silencing of cellular IKKγ by small interfering RNA led to 
enhanced replication of influenza viruses. Concomitantly, overexpression of IKKγ resulted in increased 
production of IFNα/β, whereas influenza virus infection completely eliminated the IKKγ-overexpression-
induced production of IFNα/β. Our results suggest that IKKγ and influenza virus are mutually inhibitory, 
and influenza viruses may inhibit IFN production through suppressing the expression of IKKγ during viral 
infection.  
 







    NF-κB is an important transcription factor and plays a critical role in antiviral defense (Balachandran et 
al., 2011; Munir et al., 2011; Santoro et al., 2003). NF-κB normally binds to its inhibitor, IκB and is 
localized in the cytosol in its inactivated form. Upon virus infection, the virus-activated IκB kinase (IKK) 
phosphorylates IκB, resulting in its degradation through the ubiquitin-dependent pathway. The freed NF-
κB then translocates to the nucleus and initiates the transcription of antiviral cytokines including type I 
interferons (IFNs), which are major components of host innate antiviral defense (Bernasconi et al., 2005; 
Bonnet et al., 2000). IKK is a trimeric protein complex consisting of two catalytic subunits, IKKα and IKKβ, 
and a regulatory subunit, IKKγ. IKKγ (also termed NEMO or IKBKG) regulates the kinase activity of 
IKKα/β (Rothwarf et al., 1998). IKKγ-deficient cells lack the ability to activate NF-κB in response to 
multiple stimuli (Yamaoka et al., 1998).  
    Influenza A viruses, belonging to the Orthomyxoviridae family with 8 segmented genes (Bouvier and 
Palese, 2008), continue to be a threat to human health. It has been well established that influenza viral 
protein NS1 plays a vital role in suppressing IFN production (Garcia-Sastre, 2001; Geiss et al., 2002; Jia 
et al., 2010). In this regard, one important host antiviral factor is protein kinase R (PKR), which is a 
serine/threonine protein kinase functioning upstream of IKK in activating NF-κB.  PKR is activated by 
binding to dsRNA, and the activated PKR in turn activates the IKK complex through physically binding to 
IKKβ (Bonnet et al., 2000). Viral protein NS1 is known to suppress the activation of NF-κB through either 
competitively binding to dsRNA (Wang et al., 2000), or directly interacting with PKR to block its activation 




regulatory factor 3 (IRF-3), which is a key regulator of IFN gene expression (Au et al., 1995). dsRNA-
bound NS1 was reported to prevent retinoic acid-inducible gene I (RIG-I)-mediated activation of IRF-3 
(Garcia-Sastre et al., 2007). Furthermore, NS1 protein can bind to a 30-kDa subunit of the cleavage and 
polyadenylation specificity factor (CPSF) to mediate the inhibition of posttranscriptional processing of 
cellular mRNAs, resulting in blockage of the nuclear export of newly synthesized cellular mRNAs 
including IFNs and IFN-stimulated genes (Das et al., 2008; Kim et al., 2002; Krug et al., 2003). However, 
NS1 from some influenza virus strains, including the A/PR/8/34 (H1N1) strain, may have lost the CPSF 
binding capability (Krug and Kuo, 2009; Martinez-Sobrido et al., 2007).  
In the present study, through a two-dimensional gel electrophoresis (2-DE) based comparative 
proteomic approach, we found that the expression of IKKγ was suppressed by influenza virus during viral 
infection. Functional validation experiments demonstrated that IKKγ and influenza virus were mutually 
inhibitory. Our results suggest that influenza viruses may inhibit IFN production via suppressing the 









Cell Culture and Virus Infection. Human embryonic kidney 293T cells, human lung epithelial A549 cells 
and Madin-Darby canine kidney (MDCK) cells (ATCC, Manassas, VA) were cultivated in Dulbecco 
modified eagle medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
(FBS, Hyclone Laboratories, Logan, UT) and 1% penicillin and streptomycin. Influenza A/PR/8/34 H1N1 
viruses (ATCC, Manassas, VA) were propagated and titrated in MDCK cells as described (Coico, 2006). 
For virus infection, cells at 90-95% confluency were washed twice with phosphate buffered saline without 
Mg2+ and Ca2+ (DPBS) followed by incubation with viruses at the indicated multiplicity of infection (MOI) 
for 1 hour in a humidified incubator at 37°C with 5 % CO2. The virus solution was then aspirated, and cells 
were incubated with virus growth medium [DMEM with 0.2% BSA, 25 mM HEPES, 2 mM L-glutamine, 
sodium pyruvate, 2 µg/ml tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin and antibiotics] 
at 37 °C in a 5% CO 2 incubator. For control, the same amount of virus growth medium was used in place 
of virus solution. Other procedures were the same as the procedures for the virus infection. 
2-DE. Ten hours postinfection, the mock- and virus-infected A549 cells were harvested, washed twice 
with isotonic buffer (10 mM Tris-HCL, pH 7.5 and 250 mM sucrose), and lysed with rehydration buffer (8 
M urea, 2% w/v CHAPS, 50 mM DTT, 0.2% w/v Bio-Lyte and 0.002% w/v bromophenol blue). After 
centrifugation at 50,000 g for 30 minutes at room temperature, the supernatant was collected, and the 
protein concentration was determined using a RC DC protein assay kit (BioRad, Hercules, CA) for 2-DE 
fractionation. Briefly, 450 µg of protein was loaded onto a 17 cm ReadyStrip IPG strip (pH 3-10 or 4-7), 




IEF Cell using the following conditions: 250 V for 20 minutes with a linear ramp, 10,000 V for 1 hour with 
a linear ramp, and 10,000 V for a total of 50,000 V/h with a rapid ramp. Other procedures were performed 
according to the manufacturer’s instructions (BioRad, Hercules, CA).    
Mass Spectrometry (MS) Analysis and Database Search. In-gel digestion was performed as described 
previously (Du et al., 2009; Du et al., 2006; Gu et al., 2004), and liquid chromatography – tandem mass 
spectrometry (LC-MS/MS) analysis was carried out using a LTQ-XL mass spectrometer (Thermo, San 
Jose, CA) in the Proteomic Facility at the University of Arkansas for Medical Sciences (Little Rock, AR). 
Briefly, proteins were in-gel-digested with trypsin (Promega, Madison, WI) overnight at 37 °C, and the  
resulting peptides were dissolved in 20 µl 0.1% formic acid for LC-MS/MS analysis. In the MS analysis, 
peptides were separated by an IntegraFrit column (10 cm × 50 µm ID; New Objective, Woburn, MA). 
Solvent A was 0.5% acetonitrile and 0.1% formic acid, and solvent B was 75% acetonitrile and 0.1% 
formic acid. The gradient started with a mixing of A:B = 95:5 and increased to A:B = 60:40 over 30 min. 
The flow rate was 500 nl/min. The LTQ-XL was operated in ESI positive-ion mode with the following 
settings: collision-induced dissociation (CID) fragmentation, data-dependent acquisition, and centroid 
mode for both MS and MS/MS spectrum recordings. MASCOT (Version 2.2; Matrix Science, Boston, MA) 
was used to search against a target-decoy (Elias et al., 2005) International Protein Index (IPI) human 
protein database (version 3.68) or Swiss-Prot database taxonomic field for virus (version 51.6) using LC-
MS/MS data as described (Du et al., 2009; Du et al., 2006; Gu et al., 2004). The parameters for database 
searching were as follows: (i) 2.0 Da mass error tolerance for MS and 0.65 Da for MS/MS, (ii) a maximum 
of one missed cleavage, and (iii) variable modifications: acetylation at peptide N terminus, 




peptides with a score of more than 44 (p < 0.05) were considered as positive identification. Search results 
were further processed by Scaffold software (version 2_06_00; Proteome Software, Portland, OR) for 
viewing protein and peptide identification information. In the Scaffold analysis, protein identification 
probability with at least two peptides was set to 99% and the peptide identification probability was set to 
95%. For the target-decoy database search, the false-positive rate for peptide identification was <5%. 
Plasmid DNA Construction and Transfection. For the generation of NS1 expression plasmid, NS1 
cDNA (GenBank accession no: CY021961) was inserted into the BamH I and Xho I sites of pcDNA3.1 
vector (Invitrogen, Carlsbad, CA) to generate pcDNA3.1-NS1. IKKγ (GenBank accession no: 
NM_003639.3) was amplified from a human cDNA library using primers with BamH I and Xho I sites 
(forward: 5’-GGATCCACCATGAATAGGCACCTCTGGAAG-3’ and reverse: 5’-
CTCGAGCTACTCAATGCACTCCATGAC-3’) and inserted into a pcDNA3.1 vector. All expression 
plasmids were verified by DNA sequencing. Expression plasmid was transiently transfected into 293T 
cells with the standard calcium phosphate method [basic protocol, (Kingston et al., 2001)]. 
Western Blotting. Western blotting was performed as described previously (Du et al., 2009; Du et al., 
2006; Liu et al., 2005). Mouse monoclonal anti-NS1 antibody was a gift from Dr. Stephan Ludwig at the 
University of Muenster (Muenster, Germany). Rabbit polyclonal anti-IKKγ antibody was purchased from 
Santa Cruz Biotech (Santa Cruz, CA). 
RNA Interference (RNAi). siRNA fragment (5’-GAGAAUCAAGAGCUCCGAGAUGCUU-3’) targeting 
IKKγ was designed using a tool from the Whitehead Institute (http://www.whitehead.mit.edu/index.html). A 
randomized siRNA sequence (Shanghai GenePharma Co., Ltd., Shanghai, China) was used as the 




RNAiMAX (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. Briefly, A549 cells 
were seeded in a 6-well plate (3×105 cells/well) in DMEM with 10% FBS one day before transfection. Five 
µl Lipofectamine™ RNAiMAX reagent and 120 pmol siRNA were diluted in 250 µl Opti-MEM I reduced 
serum medium (Invitrogen, Carlsbad, CA) respectively, followed by mixing the diluted siRNA with the 
diluted reagent. After incubation at room temperature for 20 minutes, the mixture was added to the cells 
with a pipette. The cells were then incubated at 37 °C in an incubator with 5% CO 2 for 48 hours. The 
IKKγ-silenced as well as control cells were either harvested for analysis or infected by viruses for further 
treatments. 
Plaque Assay.  For influenza A/PR/8/34 virus plaque assay, 95% confluent MDCK cells in each well of 
the six-well plate were washed twice with warm DPBS and then incubated with 200 µl 10-fold serially 
diluted viruses for 1 hour at a 35 °C incubator wit h 5% CO2. The plates were swirled every 15 minutes. 
Cells were then overlaid with 3 ml overlay medium containing 1% agarose and 2 µg/ml TPCK-trypsin in 
diluted DMEM (diluted by 30% with DPBS). After incubation in a 35 ºC incubator with 5% CO2 for 96 
hours, the agarose was removed and 2 ml of 70% ethanol was added to each well, followed by incubation 
of the plates at room temperature for 20 minutes. Cells were then stained with 0.3% crystal violet solution 
for 10 minutes for visualization of the plaques. Virus titer was expressed as PFU/ml determined by dilution 
factors and plaque numbers. 
Quantitative Real Time PCR (qRT-PCR). RNA was extracted from cells using the RNeasy Mini Kit 
(Qiagen, Valencia, CA), and the first strand of cDNA was synthesized from 1 µg of RNA using the iScript 
cDNA synthesis kit (BioRad, Hercules, CA), according to the manufacturer’s instructions. The IFNα/β and 




2004). mRNA abundance was measured using SYBR Green Supermix (Invitrogen, Carlsbad, CA) from 
three independent sample preparations. Relative gene expression of IFNα/β was calculated in the 
traditional 2−∆∆Ct method (Livak and Schmittgen, 2001). 
Statistical Analysis. Statistical analysis was performed using an independent-sample T test by Systat 13 






Results and Discussion 
Identification of the Proteins Whose Expression is Affected by Influenza Viral Infection. In order to 
identify the proteins whose expression was affected by influenza viral infection, we infected human lung 
epithelial A549 cells with influenza A/PR/8/34 (H1N1) viruses at an MOI of 1. Ten hours postinfection, 
mock- and virus-infected cells were harvested and analyzed by 2-DE. We analyzed the proteins using 2-
DE with IPG strips of both pH 4-7 and 3-10 to increase the chance of protein identification (Fig. 1). After 
2-DE, the differences in protein spot intensity between the control gel (the gel that resolved the proteins 
from mock-treated cells) and the “virus” gel (the gel that resolved the proteins from virus-infected cells) 
were quantified by PDquest (BioRad, Hercules, CA). Protein spots with a more than 2-fold change in 
intensity were excised for LC-MS/MS analysis. Table 1 lists the identified proteins, which can be classified 
into several different biologically functional areas. Most of the identified proteins were in the expected size 
and pH ranges on the 2D-PAGE gel. However, a few of the proteins were identified in unexpected 
locations on the 2D-PAGE gel. For example, the full length heat shock cognate 71 kDa protein (HSPA8) 
has a theoretical molecular weight of 71 kDa, but the protein was identified in spot 3, which was close to 
the molecular weight marker of 25 kDa (Fig. 1). When we examined the peptides identified by MS, we 
found that the 15 unique peptides detected by MS all matched to the first 236 residues at the N-terminal 
end of HSPA8 (Supplemental Fig. S1), suggesting that the HSPA8 in spot 3 was a truncated but not the 
full-length version of the protein. One issue in protein identification that has some uncertainties is that 




needed to examine the actual levels of changes in the expression of those proteins in the IAV infected 
cells.  
Among the identified proteins, some have been previously reported to be related to influenza virus 
infections. For example, the expressions of enoyl-CoA hidratase (mitochondrial precursor) and 
glutathione S-transferase were reported to be altered by avian influenza H9N2 and H5N1 viruses, 
respectively (Liu et al., 2008; Zhang et al., 2008). The expression of vimentin was found to be up-
regulated by influenza H1N1 viruses (Coombs et al., 2010). Identification of those proteins that have been 
reported from other research groups to be related to influenza viruses serves as a good validation of our 
current experimental approach. In addition to the proteins that have been reported previously, we also 
identified multiple proteins that have not been reported previously, such as eukaryotic translation initiation 
factor (EIF) (different isoforms), eukaryotic elongation factor (different isoforms) and IKKγ. EIFs are 
involved in initiating protein synthesis. It is known that host cellular protein synthesis in influenza virus 
infected cells is shutdown by viral elements, leaving the exclusive translation of viral mRNAs (Inglis, 1982; 
Lyles, 2000). Specifically, viral protein NS1 recruits EIF4GI (the large subunit of the cap-binding complex 
EIF4F) to the 5' untranslated region of the viral mRNA to facilitate the preferential translation of the viral 
mRNA (Aragon et al., 2000; Burgui et al., 2003). The highly confident identification of EIF4H (5 unique 
peptides and 21% sequence coverage) in the present study suggests that EIF4H may also play an 
important role in regulating viral and host protein expression in virus infected cells.  
IKKγ Expression Is Suppressed by Influenza Viruses. One more protein that was identified in this 
study but has not been reported to be related to influenza viral infection was IKKγ, whose expression was 




confidence, having 5 unique peptides and a 12% protein sequence coverage (Fig. 2). We decided to 
choose this protein for further analysis because IKKγ is known to play an important role in regulating the 
NF-κB pathway (Rothwarf et al., 1998), a pathway that determines the production of IFNs (Bonnet et al., 
2000; Wang et al., 2000). Fig. 3 shows results of a Western blot analysis of mock- and virus-infected 
A549 cells. Consistent with the 2-DE results (Table 1 and Fig. 1), Western blot analysis demonstrated that 
IKKγ expression was indeed suppressed by influenza viral infection (Fig. 3). 
IKKγ Inhibits Influenza Virus Replication. In order to test whether the alteration in IKKγ expression 
affects influenza viral replication, we used an RNAi technique to suppress the expression of endogenous 
IKKγ in A549 cells and examined its effect on viral replication. We first transfected the A549 cells with 
siRNA oligos targeting the IKKγ sequence. Western blot analysis demonstrated that the expression of 
IKKγ was suppressed by 80% (judged by image analysis with ImageJ) by the siRNA (Fig. 4A; upper 
panel). We then infected the mock-treated (non-silenced) and the IKKγ-silenced A549 cells with influenza 
A/PR/8/34 at an MOI of 0.5, followed by 30 hours of incubation. Western blot analysis indicated that IKKγ 
silencing enhanced viral replication, as more viral protein NS1 was produced in the IKKγ-silenced cells 
than the mock-treated cells (Fig. 4A; middle panel). We also harvested the viruses in the supernatants of 
the control and the IKKγ-silenced cells for plaque assay. Consistent with the Western blot results (Fig. 4A; 
middle panel), the plaque assay demonstrated that silencing of endogenous IKKγ significantly raised virus 
titers (p < 0.05) (Fig. 4B and C). Results from this and previous sections (Figs. 1, 3 and 4) suggest that 
endogenous IKKγ plays an inhibitory role in influenza viral replication in the infected host cells, and 




Influenza Viruses may Inhibit IFNα/β Production through Suppressing IKKγ Expression. It is well-
known that IKKγ is an important immune regulatory factor in activating NF-κB, which can promote the 
transcription of anti-apoptosis factors and immune cytokines, such as IFNα/β (Bernasconi et al., 2005; 
Bonnet et al., 2000). Previous studies have established that influenza viruses can inhibit IFNα/β 
production in viral infected cells through several molecular mechanisms as described in the previous 
sections, but none of those reported mechanisms involves direct action on IKKγ. Results from our 2-DE 
based proteomic analysis (Table 1, Figs. 1 and 3) implied that the expression of IKKγ may be under direct 
influence of influenza viral infection. To further confirm our proteomic results, we examined the effect of 
overexpression of IKKγ on IFNα/β production. Since IKKγ can indirectly initiate the transcription of IFNs 
via activating NF-κB, we expected that overexpression of IKKγ can lead to the increased expression of 
IFNα/β. As expected, when IKKγ was overexpressed in human 293T cells (Fig. 5A), qRT-PCR analysis 
demonstrated that the levels of IFNα/β mRNA increased more than three-fold (Fig. 5B). We then 
challenged the control cells that expressed an endogenous IKKγ and the IKKγ overexpressing cells with 
influenza viruses and compared IFNα/β production between the two types of cells that differed only in 
IKKγ expression. As shown in Fig. 5C, after cells were infected with influenza viruses, the cells 
overexpressing IKKγ had slightly but significantly reduced levels of IFNα/β mRNA compared with the 
control cells expressing an endogenous IKKγ. This result contrasted sharply with what was observed in 
non-virus-infected cells shown in Fig. 5B, which demonstrated that overexpression of IKKγ increased 
IFNα/β mRNA levels. In other words, the results in Fig. 5B and C demonstrated that influenza viral 




infected cells, suggesting that influenza viruses may block IFNα/β production by affecting the expression 
of IKKγ.  
    The NF-κB pathway is one of the most important mechanisms underlying the suppression of IFNα/β 
production by influenza viruses (Santoro et al., 2003). IKKγ is the only regulatory factor in the IKK 
complex and is located upstream of the NF-κB signaling pathway. IKKγ is essential for NF-κB activation 
(Rothwarf et al., 1998; Yamaoka et al., 1998). The influenza virus must have evolved certain 
mechanism(s) to block IFNα/β production through directly or indirectly regulating this essential 
component. Viral protein NS1 has been shown to play a vital role in suppressing IFNα/β production via 
inhibiting NF-κB activation. Because NS1 exerts its effect on NF-κB activation in several previously 
reported mechanisms largely through physically binding to the target molecules such as dsRNA and PKR 
(Krug et al., 2007; Sen et al., 2006; Tan and Katze, 1998), we performed coimmunoprecipitation to 
examine whether NS1 was also associated with IKKγ during influenza viral infection. The result was 
negative, suggesting that NS1 may not be directly involved in the suppression of IKKγ expression during 
influenza viral infection (data not shown). However, the result does not exclude the possibility that NS1 
may contribute to the influenza virus infection-induced suppression of IKKγ expression in an indirect way. 
On the other hand, because the NS1 protein in the A/PR/8/34 virus strain cannot inhibit host cellular gene 
expression through binding to CPSF (Martinez-Sobrido et al., 2007), it was unlikely that the decreased 
expression of IKKγ in the virus infected cells resulted from influenza viral NS1-mediated host cellular gene 
expression inhibition. Therefore, one possibility is that the reduced expression of IKKγ in the influenza 
virus infected cells resulted from NS1-induced inhibition of NF-κB or IRF-3. Alternatively, it is also 




suppress the IKKγ expression during viral infection. The exact molecular mechanism underlying the 
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Table of Contents Synopsis and Graphic 
Through a two-dimensional gel electrophoresis based comparative proteomic approach, we found 
that the expression of IKKγ was suppressed by influenza virus during viral infection. Functional validation 
experiments demonstrated that IKKγ and influenza virus were mutually inhibitory. Our results support a 
potentially new mechanism by which influenza viruses suppress IFNα/β production — via inhibiting the 













infected cells (right panels). A549 cells at 90-95% confluency were mock-infected or infected by influenza 
A/PR/8/34 H1N1 viruses at an MOI of 1. At 10 hours postinfection, cells were harvested, lysed and 
separated on a pH 3─10 (A) or 4─7 (B) linear IPG strip, followed by an 8-16% gradient SDS-PAGE 
fractionation and coomassie blue staining. Protein spots with a more than 2-fold change in intensity were 
marked. Proteins identified by MS analysis from the marked spots are listed in Table 1. (C) An enlarged 
image of gel regions around spot 1, which contains IKKγ. When the wet gels were visually inspected, the 
















Fig. 2. Identification of IKKγ by MS. (A) IKKγ was identified by LC-MS/MS with 5 unique peptides 


















Fig. 3. Validation of the suppression of IKKγ expression in the influenza virus infected cells with Western 
blotting. (A) A549 cells were infected by influenza A/PR/8/34 at an MOI of 0, 0.02, 0.075 and 0.3, followed 
by 24 hours of incubation. Total protein extracted from cells was analyzed by Western blotting with anti-
IKKγ. β-actin was used as a loading control. (B) Quantitation of the intensity of IKKγ protein bands shown 






















Fig. 4. Silencing of endogenous IKKγ enhances influenza virus replication. A549 cells (3×105) were mock-
treated or transfected with siRNA targeting IKKγ, followed by 48 hours of incubation. The cells were then 
infected with influenza A/PR/8/34 at an MOI of 0.5 and incubated for 30 hours. The resulting cells were 




endogenous IKKγ leads to increased NS1 expression. (B) Silencing of endogenous IKKγ results in more 
viral plaques. A representative plaque assay for control as well as siIKKγ-treated cells is shown. (C) 
Silencing of endogenous IKKγ results in higher virus titers. Values are the means ± standard errors of five 





























Fig. 5. Overexpression of IKKγ enhances IFNα/β production and influenza viral infection eliminates IKKγ-
overexpression-induced increases in IFNα/β production. (A) Overexpression of IKKγ in 293T cells. Whole 
cell lysates from 293T cells transiently transfected with IKKγ plasmid were analyzed by Western blotting 
with anti-IKKγ. (B) Overexpression of IKKγ results in higher levels of IFNα/β mRNA. IFNα/β mRNA 
extracted from IKKγ overexpression and control cells were determined by qRT-PCR. (C) Influenza viral 
infection eliminates IKKγ-overexpression-induced increased IFNα/β production. The cells prepared in the 
same way as in (B) were challenged with influenza viruses at an MOI of 0.5. Thirty hours postinfection, 
IFNα/β mRNA levels were analyzed by qRT-PCR. Actin was used as an endogenous control. Values are 









Table 1. List of proteins whose expression is altered by the infection of H1N1 virus in A549 cells 



















response IκB kinase-gamma 1 
IPI000
02411 5 5 12 122 < 0.2 
ATPase RuvB-like 2 1 IPI000
09104 




initiation factor 4H 2 
IPI000








Isoform 1 of 
Triosephosphate 
isomerase 
4 IPI00465028 10 19 42 420 > 6.6 
Aldo-keto reductase 
family 1 member C1 2 
IPI000
29733 10 18 35 389 2.5 
Isoform alpha-enolase 
of Alpha-enolase 2 
IPI004
65248 4 6 12 185 2.5 
Glutathione S-
transferase P 5 
IPI002
19757 10 35 61 797 2 
Enoyl-CoA hydratase, 
mitochondrial precursor 6 
IPI000















Vimentin 8 IPI00418471 12 14 29 204 3.5 
Tubulin beta chain 9 IPI00011654 17 73 43 980 3.4 
Ezrin 10 P15311 12 24 17 645 0.2 
Heat shock cognate 71 
kDa protein 3 
IPI000
03865 15 65 28 652 2.2 




11 49 55 1143 > 6.6 
a Spot numbers correspond to those on Fig. 1. 





Supplementary Figure S1. Identification of the truncated HSPA8 by liquid chromatography tandem mass 
spectrometry (LC-MS/MS). Partial HSPA8 was identified by LC-MS/MS with 15 unique peptides 





1, Potential mechanism underlying the regulation of IKKα/β by IKKγ.  The two catalytic subunits of 
the IKK complex, IKKα and IKKβ, need to be phosphorylated to activate NF-κB. As the regulatory subunit, 
IKKγ forms homodimer to interact with either an IKKα/β heterodimer or an IKKβ homodimer (Miller and 
Zandi, 2001). IKKγ interacts with several different signaling molecules, by which it links upstream 
activators to phosphorylate IKKα and IKKβ. IKKγ recruits the TAK1 complex to phosphorylate IKKβ, 
leading to its activation with consequence of NF-κB activation (Israel, 2010). 
 
Two references: 
Israel, A., 2010. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb 
Perspect Biol 2, a000158. 
Miller, B.S., Zandi, E., 2001. Complete reconstitution of human I kappa B kinase (IKK) complex in yeast - 
Assessment of its stoichiometry and the role of IKK gamma on the complex activity in the absence of 
stimulation. J Biol Chem 276, 36320-36326. 
 
2, The identification of IKKγ by MS.  In the present study, the IKKγ was identified by MS with 5 unique 
peptides and a 12% protein sequence coverage. In MS protein analysis, a protein can be unambiguously 
identified by one unique peptide, and additional unique peptides identified from the protein serve as 
validation of the identification. Based on this, we viewed the identification of IKKγ by MS with 5 unique 
peptides as high confidence identification. A 12% protein sequence coverage in MS protein identification 
is not very high, but is acceptable.  The number of peptide matching to a protein and sequence coverage 
50 
 
in MS analysis are affected by many factors, such as protein abundance, sample complexity, protein 
sequence, MS instrument setting, and variations from batch to batch in MS analysis, etc. Therefore, it is 
not so meaningful to compare the number of peptide identified and sequence coverage for one protein in 
one analysis with those for another protein in a separate analysis.        
 
3, Statistic analysis for figure 5B/C. The data were from three separate, independent sample 
preparations. Specifically, we prepared 3 treated and 1 control samples for each analysis and repeated 
the analysis 3 times. So, the values for the treated samples were the averages of 9 separate sample 
preparations, and the values for the control were the averages of three separate sample preparations.  In 
the calculation for fold change induced by treatment, the value for control sample was set to 1 for each 
analysis. Therefore, there were no variations for the values (hence error bars) for the controls. The values 
in Figure B for treated samples were 3.19 ± 0.91 for IFN-α and 3.16 ± 0.46 for IFN-β and in Figure C were 















Chapter 2. hnRNP A2/B1 Interacts with the Influenza A Viral Protein NS1 and Inhibits Its 
Expression and Viral Replication 
 
 
Yimeng Wang, Jianhong Zhou, and Yuchun Du* 











The NS1 protein of influenza virus is a major virulence factor and contributes significantly to virus 
pathogenesis. The multifunctional NS1 protein exerts its function through interacting with viral/cellular 
RNAs and proteins. In this study, we identified heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP 
A2/B1) as an interacting partner of NS1 protein by a two-dimensional gel electrophoresis-based 
proteomic approach and mass spectrometry. We verified the interaction between hnRNP A2/B1 and NS1 
by reciprocal coimmunoprecipitations and observed that the two proteins colocalize to each other in the 
nucleus at the early stage of infection by confocal microscopy. Knockdown of hnRNP A2/B1 by small 
interfering RNA (siRNA) resulted in increased synthesis of NS1 viral RNA and NS1 mRNA in the virus-
infected cells. In addition, we demonstrated that hnRNP A2/B1 is associated with NS1 and NS2 mRNAs, 
and siRNA-mediated knockdown of hnRNP A2/B1 promotes transport of NS1 mRNA from the nucleus to 
the cytoplasm in the infected cells. Lastly, we showed that siRNA-mediated knockdown of hnRNP A2/B1 
leads to enhanced expression of NS1 protein and virus replication. Our results suggest that hnRNP 
A2/B1 plays an important inhibitory role in the replication of influenza A virus in host cells potentially 









Influenza A viruses cause contagious respiratory illness and are responsible for more than 200,000 
hospitalizations and up to 49,000 deaths each year in the United States (CDC, 2011a). Influenza A 
viruses belong to the family Orthomyxoviridae and harbor an eight segmented, single-stranded, negative-
sense RNA genome, which codes for 11 viral proteins (Hale et al., 2008). Different from most other RNA 
viruses, influenza viruses replicate in the nucleus of the infected cells (Herz et al., 1981). In the nucleus, 
the negative-sense virion RNAs (vRNAs) from the input viruses are synthesized into full-length 
complementary RNAs (cRNAs), which in turn serve as templates for the synthesis of more vRNAs. The 
resulting vRNAs are either used as templates for producing more viral mRNAs or encapsidated into 
ribonucleoprotein structures to be exported to the cytoplasm for virion assembly at the plasma 
membrane.  
Influenza viral genome segment 8 codes for NS1 protein from unspliced primary mRNA transcript and 
NS2 protein from spliced mRNA (Lamb and Lai, 1980; Robb et al., 2010). NS1 protein is localized in both 
the cytoplasm and nucleus and plays multiple roles in viral replication cycle (Hale et al., 2008; Li et al., 
1998). In the cytoplasm of infected cells, NS1 antagonizes host interferon (IFN) system through targeting 
protein kinase R (PKR) (Min et al., 2007; Wang et al., 2000b), interferon regulatory factor 3 (IRF-3) 
(Mibayashi et al., 2007), and potentially also IKKγ (Wang et al., 2012). In the nucleus, NS1 inhibits pre-
mRNA splicing and mRNA nuclear export through targeting a 30-kDa subunit of the cleavage and 
polyadenylation specificity factor (CPSF)(Das et al., 2008; Krug et al., 2003; Nemeroff et al., 1998), poly 
(A)-binding protein II (PABII) (Chen et al., 1999), and/or components of the mRNA export machinery 
(Satterly et al., 2007; Wolff et al., 1998). 
After being transcribed, the pre-mRNAs are known to associate with nuclear proteins to form 
heterogeneous nuclear ribonucleoprotein (hnRNP) complexes, which function to affect the structure or 
nucleocytoplasmic transport of mRNAs (Dreyfuss et al., 1993). The hnRNP family includes approximately 
20 proteins, ranging from hnRNPs A1 to U, and each hnRNP protein contains RNA binding motifs and 
auxiliary domains for protein-protein or protein-nucleic acid interactions (Krecic and Swanson, 1999; 




hnRNP members, such as hnRNP M, H1 (Jorba et al., 2008) and A1(Mayer et al., 2007), to modulate 
influenza virus replication in virus-infected cells.  
Like other viruses, influenza viruses depend on host cellular components, proteins in particular, to 
complete most (if not all) steps in the viral proliferation cycle, including viral gene replication/ 
transcription/translation, intracellular trafficking, and virion assembly. This kind of dependence and the 
intracellular warfare between influenza viruses and host cells create a vast plethora of interactions 
between viral components and host cellular components in virus-infected cells. Identification of the host 
cellular factors that play critical roles in viral replication cycle through interactions with viral factors may 
provide valuable information for designing novel antiviral therapy. In this study, through a two-dimensional 
gel electrophoresis (2-DE)-based proteomic method, we identified hnRNP A2/B1 as an interacting partner 
of the influenza viral protein NS1 and found that hnRNP A2/B1 affects influenza A virus replication via 





Materials and Methods 
Cell Culture and Virus Infection. Human embryonic kidney (HEK) 293T cells, human lung epithelial 
A549 cells, and Madin-Darby canine kidney (MDCK) cells (ATCC, Manassas, VA) were cultivated in 
Dulbecco modified eagle medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine 
serum (FBS, Hyclone Laboratories, Logan, UT) and 1% penicillin and streptomycin. Influenza A/PR/8/34 
H1N1 viruses (ATCC, Manassas, VA) were propagated and titrated in MDCK cells as described 
previously (Wang et al., 2012).  
Plasmid Construction and Cell Transfection. Flag tagged NS1 gene and Flag alone were cloned into 
pcDNA3.1 as described previously (Wang et al., 2012). For mammalian two hybrid assay, NS1 and 
hnRNP A2/B1 cDNAs (GenBank accession no: NM_031243) were inserted into EcoR I and Sal I sites of 
pM vector with GAL4 DNA binding domain (BD) and pVP16 vector with transcriptional activation domain 
(AD) (BD Biosciences, San Jose, CA), respectively. hnRNP A2/B1 gene was also cloned into pCruz HA 
vector (Santa Cruz Biotech, Santa Cruz, CA) by inserting the cDNA into the Not I and Bgl II sties of the 
vector. All expression plasmids were verified by DNA sequencing. Cell transfection was performed as 
described previously (Wang et al., 2012).  
Affinity Purification and 2-DE. Human 293T cells transiently transfected with plasmids expressing Flag 
alone or Flag-NS1 (approximately 1 × 109 each) were harvested and washed twice with cold phosphate-
buffered saline (PBS) 48 h after the transfection. The cells were lysed in 5 packed cell pellet volumes of a 
lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10 mM NaF, 10 mM β-
glycerophosphate, and 1 mM Na3VO4) supplemented with protease inhibitor cocktail (Roche Diagnostics, 
Indianapolis, IN) by douncing with a glass dounce homogenizer (Kontes Glass Co., Vineland, NJ). After 
centrifugation at 20,000 g for 15 min at 4 °C, the pellets were further extracted once with the lysis buffer 
and sonication. The combined supernatants from the cells that express Flag-NS1 or the control cells that 
express Flag alone were incubated separately with 200 µl pre-washed anti-Flag M2 resin (Sigma, St. 
Louis, MO) for 5 h at 4°C. After washing (4 x 1 ml) , the bound proteins were eluted with an elution buffer 
containing 50 mM Tris-HCl pH 7.5, 0.5 M NaCl, 250 mM Flag peptide (Sigma, St. Louis, MO) and then 
concentrated by trichloroacetic acid precipitation. The precipitated proteins from the two groups of cells 




MS Analysis and Database Search. After 2-DE fractionations, the two 2-DE gels that resolved the 
affinity-purified proteins from control cells (express Flag alone) or the cells that express Flag-NS1 were 
visually inspected. The protein spots uniquely appearing in the gel that resolved the proteins purified from 
the cells that express Flag-NS1 (but not in the control gel) were excised, in-gel digested, and the resulting 
peptides analyzed by mass spectrometry. In-gel digestion, MS analysis, and database search were 
carried out as described previously (Wang et al., 2012). 
Mammalian Two-hybrid Analysis. Mammalian two-hybrid analysis of protein-protein interactions was 
performed according to our previous protocol (Du et al., 2006b; Wang et al., 2005). Briefly, the coding 
sequences of NS1 and hnRNP A2/B1 were inserted into the vectors encoding BD and AD (BD 
Biosciences, San Jose, CA), respectively, and the two constructs were co-transfected into 293T cells with 
a Gal4 GFP reporter plasmid (2 µg of each plasmid in a 60-mm plate). The negative control was 
performed by co-transfection of the 293T cells with Gal4 GFP reporter plasmid and the two expression 
vectors in which the BD and AD were fused with two proteins that are known to not interact. The 
expression of GFP was detected by Western blotting using an anti-GFP antibody. 
Co-immunoprecipitation (IP). Vectors expressing HA-hnRNP A2/B1 or Flag-NS1 were co-transfected 
into 293T cells (~1 × 108 cells). For control, the vector expressing Flag alone was used to replace the 
vector that expresses Flag-NS1 in the co-transfection. Forty-eight h after the transfection, cells were lysed 
and immunoprecipitated with anti-Flag M2 resin as described above. The NS1-associated proteins were 
detected by Western blotting using an anti-HA antibody (Santa Cruz Biotech, Santa Cruz, CA). In a 
reciprocal co-IP, cell transfection, IP, and Western blotting were performed as described above except 
that 1) for control, the vector expressing HA alone was used to replace the vector that expresses HA-
hnRNP A2/B1 in the co-transfection; 2) the IP was performed using immobilized anti-HA antibody (Santa 
Cruz Biotech, Santa Cruz, CA) (or Protein A-Sepharose beads (Sigma, St. Louis, MO) pre-incubated with 
anti-HA antibody overnight); 3) the hnRNP A2/B1-associated proteins were detected by Western blotting 
using an anti-Flag antibody (Sigma, St. Louis, MO). 
Immunofluorescence Staining and Confocal Microscopy. The immunofluorescence staining and 
image acquisition were performed as described in our previous papers (Zhou et al., 2012a, b). 




of 1. At 6 hpi, cells were washed with PBS, fixed by 4% formaldehyde in PBS for 15 min, and 
permeabilized by 0.2% Triton X-100 in PBS for 10 min. The cells were then washed and blocked with 10% 
normal goat serum in PBS for 1 h, followed by incubation with mouse anti-NS1 antibody (1:1,000) in 5% 
normal goat serum in PBS overnight at 4°C. After wa shing, the cells were incubated with fluorescein 
isothiocyanate (FITC)-conjugated goat anti-mouse secondary antibody (Santa Cruz Biotech, Santa Cruz, 
CA) for 1 h at room temperature. The cells were then washed and incubated with rabbit anti-hnRNP 
A2/B1 antibody (1:2000), followed by incubation with rhodamine-conjugated goat anti-rabbit secondary 
antibody (Santa Cruz Biotech, Santa Cruz, CA). The images were acquired by a NIKON Eclipse 90i 
confocal fluorescence microscope (Nikon, Tokyo, Japan).  
RNA Interference (RNAi). Three siRNA oligos specifically targeting hnRNP A2/B1 [5’-
AAGCUUUGAAACCACAGAAGA-3’ (Patry et al., 2003), 5’-AAAGAUCAAGAGGAUUUGGUU-3’ and 5’-
GGAACAGUUCCGUAAGCUC-3’ (Iwanaga et al., 2005)] were co-transfected into A549 cells using 
Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA) as described previously (Wang et al., 2012).  
Quantitative Real-Time PCR (qRT-PCR). The analysis was performed according to our previous 
protocol (Liu et al., 2012; Wang et al., 2012) with the following specifications. A549 cells treated with 
siRNAs oligos targeting hnRNP A2/B1 or nontargeting siRNAs (negative control) were infected with the 
A/PR/8/34 viruses. The cells were harvested and total RNA extracted using an RNeasy Mini kit (Qiagen, 
Valencia, CA) at appropriate hpi. Viral RNAs (vRNAs) and mRNA were reverse-transcribed (Improm-II 
Reverse Transcriptase kit; Promega, Madison, WI) with the Uni-12 primers (Hoffmann et al., 2001) and 
the oligo (dT) primers (Promega, Madison, WI), respectively. The levels of cDNAs reverse-transcribed 
from vRNAs and mRNAs were determined by qRT-PCR with primers specific for the NS1 gene (Forward: 
5’-GACCGGCTGGAGACTCTAAT-3’ and reverse: 5’-CTGGAAGAGAAGGCAATGGT-3’). The 
concentrations of mRNAs were determined using actin mRNA as an internal control and calculated using 
the traditional 2−∆∆Ct method (Livak and Schmittgen, 2001b). The relative levels of vRNA were determined 
based on a standard curve generated by serial dilutions of the NS1 expression plasmids used in cell 
transfection (Shin et al., 2007). Each time, we prepared three independent samples treated with siRNAs 
oligos targeting hnRNP A2/B1 and one sample treated with nontargeting siRNAs for the calculation of fold 




The Analysis of the Interaction between NS1/2 mRNAs and hnRNP A2/B1 Proteins. The vectors 
expressing HA-hnRNP A2/B1 or HA tag alone as control were transiently transfected into 293T cells. 
Forty-eight h after the transfection, the cells were infected with A/PR/8/34 viruses at an MOI of 3. Ten h 
after the infection, the cells were harvested and lysed for IP with immobilized anti-HA antibody as 
described above. The immunoprecipitated complexes were treated with 150 µg/ml proteinase K for 90 
min at 37 °C. After extraction of the total RNA fro m the immunoprecipitated complexes, oligo (dT) primer 
was used to reverse-transcribe mRNAs into cDNAs, and the following primers were then used to PCR-
amplify DNA (25 cycles) from the reverse-transcribed cDNAs: NS1 primers (Forward: 5’-
ATGGATCCAAACACTGTGTC-3’ and reverse: 5’-TCAAACTTCTGACCTAATTGTTCC-3’); GAPDH 
primers (Forward: 5’-CGGAGTCAACGGATTTGGCC-3’ and reverse: 5’-GTGGCAGAGATGGCATGGAC-
3’). The amplified DNAs were detected with a 1.3% agarose gel and further confirmed by DNA 
sequencing.   
Subcellular Fractionation. Nuclear and cytoplasmic fractionations were performed according to a 
published protocol (Wang et al., 2006b). Briefly, cells were harvested and swelled on ice in a hypertonic 
buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, and 3 mM MgCl2) for 3 min, followed by centrifugation at 
1,500 g for 3 min. The cell pellet was lysed in four packed cell pellet volumes of buffer A [10 mM Tris-HCl, 
pH 7.5, 10 mM NaCl, 3 mM MgCl2, 10% (v/v) glycerol, 0.5% (v/v) NP-40, 0.5 mM DTT, and 100 U/ml 
RNasin or 1x protease inhibitor]. After centrifugation at 4,500 g for 3 min at 4 °C, supernatant was saved 
as cytoplasmic fraction. The pellet was resuspended in buffer A supplemented with detergents [3.3% (w/v) 
sodium deoxycholate and 6.6% (v/v) Tween 20] and incubated on ice for 5 min. The insoluble materials 
were designated as nuclei and collected by centrifugation at 10,000 g for 5 min and washed with buffer A 
once to remove the possible residue of cytoplasmic fraction. The integrity of the isolated nuclei was 
examined by microscopy after staining with trypan blue. The total RNAs were extracted from the 
cytoplasmic and nuclear fractions and the isolated RNAs were treated with RNase-free DNase I 
(Invitrogen, Carlsbad, CA) at room temperature for 15 min, followed by incubation at 37 °C for 30 min to 
remove genomic DNAs. Three micrograms of the resulting RNAs were reverse transcribed into cDNAs as 
described above. 18S-rRNA was used as an internal control in the qRT-PCR (Zhu and Altmann, 2005). 




Statistical Analysis. Statistical analysis was performed using an independent-sample T test by Systat 13 





Identification of hnRNP A2/B1 as an Influenza Virus NS1 Interacting Protein. We used a 2-DE-based 
proteomic method to identify the proteins that were associated with influenza viral protein NS1 (Zhou et 
al., 2012a). Two populations of 293T cells were transiently transfected with plasmids that express Flag 
alone (control) and Flag-NS1, respectively. After affinity purification of the whole cell lysates from the two 
populations of cells, the bound proteins eluted from the affinity beads were fractionated with two identical 
2-DE gels. The protein spots uniquely appearing in the gel that resolved the proteins purified from the 
cells that expressed Flag-NS1, were excised, in-gel digested, and the resulting peptides analyzed by MS. 
One of the proteins that were identified by MS was hnRNP A2/B1, which is produced by alternative 
splicing from a single gene and has been shown to play important roles in RNA processing like RNA 
transport, translation, stabilization, splicing and trafficking (Kamma et al., 1999). hnRNP A2/B1 was 
identified with high confidence by MS with 18 unique peptides to the proteins and a 58% sequence 
coverage (Supplemental Fig. S1). Several other proteins were also identified to potentially interact with 
NS1, such as RUVBL1 and RUVBL2, which will be reported in a separate paper. 
Validation of the Interaction between hnRNP A2/B1 and NS1 by Co-IPs and Mammalian Two-hybrid 
Analysis. We used co-IPs to validate the interaction between NS1 and hnRNP A2/B1. As shown in Fig. 
1A, immobilized anti-Flag antibodies precipitated large amount of HA-hnRNP A2/B1 from the cells co-
transfected with the plasmids that express Flag-NS1 and HA-hnRNP A2/B1, but precipitated much less 
amount of the proteins from the cells co-transfected with the plasmids that express Flag alone and HA-
hnRNP A2/B1 (upper row). Similarly, in a reciprocal IP, immobilized anti-HA antibodies precipitated large 
amount of Flag-NS1 from the cells co-transfected with the plasmids that express Flag-NS1 and HA-
hnRNP A2/B1, but failed to do so from the cells co-transfected with the plasmids that express HA tag 
alone and Flag-NS1 (lower row). These results strongly suggest that NS1 is specifically associated with 
hnRNP A2/B1. hnRNP A2/B1 is an RNA binding protein (Han et al., 2010b). In order to test whether the 
NS1-hnRNP A2/B1 interaction is mediated by RNAs, we used RNase (Sigma, St Louis, MO) to treat the 
cell lysates before the IPs. The results demonstrated that the RNase treatment did not change the 
association of NS1 with hnRNP A2/B1 in the reciprocal co-IPs (data not shown), suggesting the 




NS1 and hnRNP A2/B1 interact in vivo in cells, we performed mammalian two-hybrid assays. In this 
assay, the interaction between hnRNP A2/B1 and NS1 brings the association of Gal4 BD and AD, which 
in turn initiates the transcription of a reporter gene GFP (Du et al., 2006a). Co-transfection of 293T cells 
with the Gal4 GFP reporter plasmid and the constructs encoding fusion proteins of BD-NS1 and AD-
hnRNP A2/B1 resulted in higher expression of GFP than the negative control, in which BD and AD were 
fused with two proteins that are known to not interact (Fig. 1B, compare the right lane with the left lane). 
These results suggest that NS1 interacts with hnRNP A2/B1 in human cells in vivo. 
hnRNP A2/B1 Colocalizes with NS1 in Human Lung A549 Cells.  We then performed immunostaining 
and confocal microscopy analysis using human lung A549 cells to determine whether viral NS1 and 
hnRNP A2/B1 physically colocalize to each other in cells. A549 cells were infected with A/PR/8/34 viruses 
and fixed at 6 hpi, followed by incubation with anti-NS1 and anti-hnRNP A2/B1 antibodies and appropriate 
fluorescence-labeled secondary antibodies. Confocal microscopy analysis of the stained cells 
demonstrated that hnRNP A2/B1 was predominantly located in the nucleus; while the majority of NS1 
protein in the infected cells was located in the nucleus, a small portion of it was located in the cytoplasm 
at 6 hpi, which was also observed by other research groups (Li et al., 1998; Wolff et al., 1998). Merge of 
the hnRNP A2/B1- and NS1-stained images strongly suggest that hnRNP A2/B1 and NS1 colocalize to 
each other in the nucleus of the infected cells at 6 hpi (Fig. 2).  
hnRNP A2/B1 Suppresses NS1 Protein Expression in the Virus-infected Cells. To determine the 
potential roles of the interaction between hnRNP A2/B1 and NS1, we silenced the expression of 
endogenous hnRNP A2/B1 by siRNAs in A549 cells and then examined the effect of the hnRNP A2/B1 
silencing on NS1 protein expression in the virus-infected cells. The results demonstrated that when the 
expression of hnRNP A2/B1 was silenced by siRNAs (Fig. 3; upper row), viral NS1 protein expression 
increased (Fig. 3; middle row), suggesting that hnRNP A2/B1 plays an inhibitory role in the protein 
expression of NS1 in the virus-infected cells.  
hnRNP A2/B1 Inhibits NS1 vRNA Replication and mRNA Transcription in the Virus-infected Cells. 
To elucidate the mechanism by which hnRNP A2/B1 inhibits viral NS1 protein expression in the virus-
infected cells, we examined the effect of knockdown of hnRNP A2/B1 expression on NS1 gene replication 




of hnRNP A2/B1 increased NS1 vRNA levels by 1.4-fold (1.4 ± 0.05) and 2.1-fold (2.1 ± 0.1) (Fig. 4A) and 
NS1 mRNA levels by 1.2-fold (1.2 ± 0.04) and 1.7-fold (1.7 ± 0.07) at 24 hpi and 36 hpi (Fig. 4B), 
respectively. These results suggest that hnRNP A2/B1 inhibits both viral NS1 gene replication and 
transcription in the virus-infected cells. 
hnRNP A2/B1 Binds to NS1 and NS2 mRNAs, Does Not Affect NS mRNA Splicing, but Inhibits NS1 
mRNA Nuclear Export. hnRNP proteins are known to regulate splicing (Caputi et al., 1999; Han et al., 
2010b) and nuclear export of mRNAs (Reed and Hurt, 2002; Schneider and Wolff, 2009). Thus, we tested 
whether hnRNP A2/B1 plays a role in regulating the splicing and nuclear export of NS1 mRNA in the 
virus-infected cells. For this purpose, we first examined whether hnRNP A2/B1 proteins are associated 
with NS1 or NS2 mRNAs. 293T cells were transfected with the plasmids that express HA-hnRNP A2/B1 
or HA tag alone for control, and then infected with A/PR/8/34 viruses at an MOI of 3. Ten h after the 
infection, the cells were harvested for IPs with immobilized anti-HA antibodies to pull down the complexes 
that were associated with hnRNP A2/B1. After the IPs, proteinase K was used to release the hnRNP 
A2/B1-associated RNAs from the precipitated complexes, and total RNA was purified, followed by 
reverse-transcription with oligo (dT) primer to reverse-transcribe the mRNAs [leaving vRNA and cRNA un-
affected (Robb et al., 2010)], and PCR amplification of the reverse-transcribed cDNAs. Because the 
primers we used in the PCR amplification were specific for the cDNAs of both NS1 and NS2 mRNAs (Fig. 
5A), the amounts (or presence/absence) of both NS1 and NS2 mRNAs in the precipitated complexes 
could be detected simultaneously. As shown in Fig. 5B, transfection of the cells with the plasmid that 
expresses HA-hnRNP A2/B1 did not affect the transcription of either NS1 or NS2 (left panel). The 
immobilized anti-HA antibody precipitated substantially more NS1 and NS2 mRNAs from the cells that 
express HA-hnRNP A2/B1 than from the control cells. These results suggest that both NS1 and NS2 
mRNAs are specifically associated with hnRNP A2/B1 proteins in the virus-infected cells.  
    After confirming that NS1 and NS2 mRNAs are associated with hnRNP A2/B1 proteins in the virus-
infected cells, we examined whether hnRNP A2/B1 proteins affect NS pre-mRNA splicing. To test this 
possibility, we compared the ratios of NS2 to NS1 mRNAs in the infected cells with a normal level of 




described above. The results demonstrated knockdown of hnRNP A2/B1 by siRNAs does not affect the 
NS1 and NS2 splicing in the virus-infected A549 cells (data not shown).  
We then examined the potential role of hnRNP A2/B1 in nucleocytoplasmic translocation of NS1 
mRNAs. We used a differential-centrifugation-based method (Wang et al., 2006b) to fractionate cell 
lysates into cytoplasmic and nuclear parts. Western blot analysis using marker proteins of the cytoplasm 
and nucleus demonstrated that there were no noticeable cross-contaminations in our cytoplasmic and 
nuclear fractionations (Fig. 6A). We then transfected the A549 cells with the siRNAs oligos targeting 
hnRNP A2/B1 or with a negative control siRNA, and infected the transfected cells with A/PR/8/34 viruses. 
The transfected and infected cells were harvested and fractionated, and NS1 mRNAs in the cytoplasmic 
and nuclear factions quantified by qRT-PCR. The results demonstrated that when hnRNP A2/B1 
expression was silenced by siRNAs, the ratios of the cytosolic to nuclear NS1 mRNAs at 6 and 10 hpi 
increased (Fig. 6B). These results suggest that hnRNP A2/B1 proteins inhibit the nuclear export of viral 
NS1 mRNAs in the virus-infected cells.  
hnRNP A2/B1 Inhibits Influenza Virus Replication. Since hnRNP A2/B1 affects influenza viral NS1 
gene replication, transcription (Fig. 4), expression (Fig. 3) and NS1 mRNA nuclear export (Fig. 6), we 
speculated hnRNP A2/B1 may affect virus replication. Indeed, when the expression of hnRNP A2/B1 was 
silenced by siRNAs in the A549 cells, the virus titers increased (Fig. 7), suggesting that hnRNP A2/B1 






Although NS1 protein is not part of the influenza virion, it is expressed at very high level in the virus-
infected cells (Lazarowitz et al., 1971; Liu et al., 2012). NS1 is a multifunctional protein (Hale et al., 2008). 
One major function of NS1 is to inhibit host immune responses through suppressing the induction of type 
I IFNs and IFN-mediated proteins (Krug et al., 2003). In addition to its role in inhibiting host immune 
responses, NS1 also plays important roles in other aspects in the virus-infected cells (Hale et al., 2008). 
For example, NS1 has been shown to affect mRNA splicing and nuclear export (Garaigorta and Ortin, 
2007), protein synthesis (de la Luna et al., 1995; Enami et al., 1994), and cell apoptosis (Ehrhardt et al., 
2007a). Most, if not all, of the reported functions of NS1 are realized through the physical interactions with 
cellular/viral proteins or RNAs (Hale et al., 2008). In the present study, through a 2-DE-based proteomic 
approach, we found that NS1 is associated with hnRNP A2/B1, a member of a large family of proteins 
that are highly divergent in structure and function (Han et al., 2010b; Shyu and Wilkinson, 2000). hnRNP 
A2 and B1 proteins are produced by alternative splicing of a single gene with the difference of a 12-
amino-acid insertion in N-terminal RNA-binding motif in B1 (Burd et al., 1989; Kozu et al., 1995). hnRNP 
A2/B1 has been shown to regulate RNA alternative splicing (Bilodeau et al., 2001; Mayeda et al., 1994), 
RNA trafficking (Munro et al., 1999; Pinol-Roma, 1992; Shan et al., 2003), and telomere maintenance 
(Ford et al., 2002).  
Most cellular mRNAs are transported from the nucleus to the cytoplasm through the mRNA export 
receptors Tap/NXF1 that interact with both mRNAs and components of the nuclear pore complex to direct 
mRNAs through the nuclear pore complex (Stutz and Izaurralde, 2003). The interaction between mRNA 
and Tap/NXF1 is mediated by adapter proteins such as Aly (Strasser and Hurt, 2000; Stutz et al., 2000), 
which is recruited to the mRNA during splicing by export factor UAP56 (Gatfield et al., 2001; Luo et al., 
2001). Several lines of evidence suggest that viral mRNA export in the virus-infected host cells is 
mediated by the Tap/NXF1 export pathway (Hao et al., 2008; Wang et al., 2008), and viruses have 
evolved strategies to introduce viral mRNAs into the Tap/NXF1 export system through recruiting cellular 
export factors, such as export factors Aly and UAP56 (Chen et al., 2005; Koffa et al., 2001; Lischka et al., 
2006). In the case of influenza viral mRNA nuclear export, it seems that NS1 protein plays an important 




factors (Schneider and Wolff, 2009). In supporting this notion, it has been shown that NS1 proteins from 
influenza A and B viruses interact with mRNA export factors Tap/NXF1 and UAP56, respectively (Satterly 
et al., 2007; Schneider et al., 2009), to facilitate nuclear export of viral mRNAs (Schneider and Wolff, 
2009). In the present study, we found that nuclear protein hnRNP A2/B1 interacts with both NS1 proteins 
(Fig. 1) and NS1 mRNAs (Fig. 5), and inhibits the nuclear export of NS1 mRNAs in the virus-infected cells 
(Fig. 6). A potential mechanism underlying the inhibitory effect of hnRNP A2/B1 on viral NS1 mRNA 
nuclear export is that the interaction of hnRNP A2/B1 with NS1 protein interferes NS1 protein’s ability to 
recruit mRNA export factors such as Tap/NXF1 or other factors to the NS1 mRNAs (Satterly et al., 2007; 
Schneider and Wolff, 2009). It has been shown that influenza viral NS1 protein is associated with 
influenza viral mRNAs of NA, M1, and PB1 genes (Wang et al., 2008). If the hypothesis described above 
is correct, it is highly likely that hnRNP A2/B1 may also play an important role in regulating the nuclear 
export of other influenza viral mRNAs including (but not limited to) those of NA, M1, and PB1 (Wang et 
al., 2008).  
We also found in the present study that knockdown of hnRNP A2/B1 expression by siRNA resulted in 
increased synthesis of viral NS1 vRNA and mRNA (Fig. 4), suggesting that endogenous hnRNP A2/B1 
inhibits NS1 gene replication and transcription in the virus-infected cells. Because the viral mRNAs 
exported from the nucleus are translated into viral proteins in the cytoplasm, and some of the resulting 
viral proteins are transported back to the nucleus to facilitate the new viral particles assembly with vRNAs, 
it is highly likely that the observed increases in viral RNA replication and transcription of NS1 gene (Fig. 4) 
were a consequence of the increased nuclear export of NS1 mRNA (Fig. 6) when the expression of 
hnRNP A2/B1 was silenced (Fig. 3). Alternatively, since hnRNP proteins are formed by the association of 
nuclear proteins and pre-mRNAs that are transcribed by RNA polymerase II, pre-mRNAs may bridge the 
association between hnRNP proteins and RNA polymerase II, which is also required for influenza viral 
RNA transcription. So it is also theoretically possible that the NS1-hnRNP A2/B1 complex affects the 
catalytic activity of RNA polymerase II with consequence of affecting both viral RNA transcription and 
nuclear export. This interpretation is consistent with the results obtained from the RNA polymerase 
inhibitor-based studies (Amorim et al., 2007). Future studies will be needed to examine how hnRNP 




mediated transcription of NS1 [and potentially other viral genes (Wang et al., 2008)] in the virus-infected 
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Fig. 1. Validation of the interaction between hnRNP A2/B1 and NS1. A, co-IPs. Cell lysates from the cells 
expressing Flag-NS1 and HA-hnRNP A2/B1, or the cells expressing Flag alone and HA-hnRNP A2/B1 
(control), were immunoprecipitated with anti-Flag M2 resin, and the immunoprecipitated proteins were 
probed with anti-HA antibody in Western blotting. As shown, the anti-Flag antibody precipitated 
substantially more HA-hnRNP A2/B1 from the cells that express Flag-NS1 and HA-hnRNP A2/B1 than 
from the control cells (top panel). In a reciprocal co-IP, cell lysates from the cells expressing Flag-NS1 
and HA-hnRNP A2/B1, or the cells expressing HA alone and Flag-NS1 (control), were precipitated with 
immobilized anti-HA antibody, and the immunoprecipitated proteins were probed with anti-Flag antibody 
in Western blotting. As shown, Flag-NS1 was immunoprecipitated with HA-hnRNP A2/B1 by immobilized 
anti-HA antibody, but not from the control cells (bottom panel). B, mammalian two-hybrid analysis. 293T 
cells were co-transfected with plasmids expressing BD-NS1, AD-hnRNP A2/B1, and a Gal4 GFP reporter, 
and the induction of reporter GFP expression was detected by Western blotting with an anti-GFP 
antibody. The negative control was performed by co-transfection of 293T cells with Gal4 GFP reporter 
plasmids and constructs in which the BD and AD were fused with two proteins that are known to not 
interact. The induction of Gal4 GFP reporter by the expression of BD-NS1 and AD-hnRNP A2/B1 fusion 






Fig. 2. Colocalization of hnRNP A2/B1 with NS1 in the nucleus of the virus-infected cells. A549 cells were 
infected with A/PR/8/34 viruses at an MOI of 1, stained with antibodies directed against hnRNP A2/B1 
and NS1 at 6 hpi, and the images were acquired by using a confocal laser-scanning microscope. Merged 
image of the hnRNP A2/B1-staining (in red) and NS1-staining (in green) shows the overlap of hnRNP 
A2/B1 and NS1 in the nucleus of the infected cells at 6 hpi.  
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Fig. 5. hnRNP A2/B1 proteins are associated with NS1 and NS2 mRNAs. A, schematic representation of 
NS1 mRNA, NS2 mRNA, and the positions of the primers used to amplify NS1 and NS2 mRNAs. The 
coding regions of NS1 and NS2 mRNAs are shown as white and hatched boxes, respectively. The 
numbers above the coding regions indicate the start and end nucleotide positions in the NS1 mRNA and 
NS2 mRNA. The NS2 mRNA is alternatively spliced from NS1 mRNA, and the V-shaped line denotes the 
region that is removed in splicing. Using the primers (black bar) indicated in the diagram, the amplicon 
size for NS1 and NS2 was calculated to be 693 and 221 bps, respectively. B, hnRNP A2/B1 proteins are 




HA-hnRNP A2/B1 or HA tag alone (control) were infected with A/PR/8/34 viruses at an MOI of 3. At 10 
hpi, the cells were harvested, lysed, and the resulting whole cell lysates immunoprecipitated with 
immobilized anti-HA antibody. The immunoprecipitated RNAs were released from the complexes by 
incubating with proteinase K, reverse-transcribed, PCR-amplified with the primers indicated in (A), and 
the resulting DNAs examined by a 1.3% agarose gel. GAPDH was used as an internal reference.  
 
Fig. 6. hnRNP A2/B1 inhibits NS1 mRNA nuclear export. A, cytoplasmic and 
cells transfected with a randomized siRNA sequence (control) or 
A2/B1 were lysed and fractionated into nuclear and cytoplasmic parts, and the purity of each part was 
examined by Western blotting using antibodies against the nuclear and cytoplasmic markers (histone 
H2B and tubulin, respectively). B, hnRNP A2/B1 inhibits NS1 mRNA nucleocytoplasmic translocation. 
A549 cells transfected with randomized siRNA sequence (control) or siRNA sequence target
A2/B1 were infected with A/PR/8/34 viruses
times, fractionated into the nuclear and cytoplasmic parts, and the NS1 mRNA in each part was quantified 
by qRT-PCR. 18s-rRNA was used as an inte
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Fig. 7. Silencing of endogenous hnRNP A2/B1 enhances virus replication. A549 cells transfected with a 
randomized siRNA sequence (control) or a siRNA sequence targeting hnRNP A2/B1 were infected by 
A/PR/8/34 viruses at an MOI of 0.5. The supernatants were harvested at the indicated times for 
examinations of virus titers. Values are the means ± S.E. of three separate sample preparations. * 











Supplementary Figure S1. Identification of hnRNP A2/B1 by liquid chromatography tandem mass 
spectrometry (LC-MS/MS).  hnRNP A2/B1 was identified by LC-MS/MS with 18 unique peptides 
























Chapter 3. Ruvb-like Proteins Interact with Influenza A Virus Protein NS1 and Affect Apoptosis of 






    RuvB-like proteins 1 and 2 (RUVBL1 and RUVBL2) were identified as the binding partners of NS1 
through a 2-DE based proteomic approach and mass spectrometry. In order to explore the biological 
functions of the interactions, we examined the expression of RUVBL1 and RUVBL2 in influenza virus-
infected cells. Infection of IFN-competent A549 cells or IFN-deficient Vero cells with wild-type (WT) or 
NS1-deleted (delNS1) influenza A/PR/8/34 (H1N1) viruses reduced the expression of RUVBL1 and 
RUVBL2 in Vero cells, but only RUVBL2 in A549 cells. Infection of Vero cells with both kinds of viruses 
induced earlier expression reduction of RUVBL2 than that of RUVBL1, and delNS1 virus infection led to 
more pronounced expression reduction of RUVBL2 and cell apoptosis (evidenced by increased PARP 
cleavage and caspase 3/7 activities) than WT virus. These results suggest that (1) RUVBL2 is affected by 
virus infection prior to RUVBL1, and (2) the interaction between NS1 and RUVBL2 increases RUVBL2 
level by inhibiting virus-induced RUVBL2 reduction during virus infection. We then showed that 
knockdown of endogenous RUVBL2 in Vero cells by siRNAs induced cell apoptosis, suggesting that 
virus-induced expression reduction of RUVBL2 may promote apoptosis of the virus-infected host cells. To 
ensure RUVBL2 plays a significant role in regulating cell apoptosis, we overexpressed RUVBL2 in Vero 
cells followed by virus infection and found that overexpression of RUVBL2 resulted in increased cell 
resistance to virus-induced cell apoptosis. However, we found that the virus reduced RUVBL2 expression 
in IFN-competent A549 cells but not affect apoptosis, suggesting IFNs play a critical role in the RUVBL2-
induced apoptosis. To confirm the role of IFNs, we pre-treated the Vero cells with IFN-alpha and infected 
cells with viruses. The results were the same as the observation in A549 cells, suggesting that IFNs can 
block the apoptosis induced by the virus-induced RUVBL2 reduction. Taken together, our data suggest 
that influenza viruses reduce RUVBL2 expression to induce apoptosis of the virus-infected cells in the 
absence of IFNs and NS1 down-regulates apoptosis potentially through interacting with RUVBL2 to raise 






    RUVBL1 and RUVBL2 are putative ATPases and belong to the family of AAA+ (ATPase associated 
with diverse cellular activities) (Neuwald et al., 1999). RUVBL1 and RUVBL2 proteins consist of 456 and 
463 amino acids, respectively, and share 43% identity (Gorynia et al., 2008). RUVBL1 can form a 
hexamer, which can further form a dodecamer with RUVBL2. These two proteins were initially identified 
by different methods and therefore have different names: TIP49 and TIP48 (Wood et al., 2000), TIP49a 
and TIP49b (Kanemaki et al., 1999), Pontin52 and Reptin52 (Bauer et al., 1998) and Rvb1 and Rvb2 
(Jonsson et al., 2001). RUVBL1 and RUVBL2 are relatively conserved in evolution, suggesting that they 
mediate important cellular functions. The first role of RUVBL proteins is to couple the energy of ATP 
hydrolysis to unwind the DNA double helix, which is important for any processes requiring single-stranded 
DNA, such as DNA replication, transcription, and DNA repair. RUVBL1 contains two ATP binding sites by 
which hydrogen bonds between complementary base pairs can be destabilized (Patel and Picha, 2000). 
The second role is involved in chromatin remodeling.  RUVBL proteins have been found to regulate the 
chromatin structure to promote access of proteins to DNA (Gorynia et al., 2008). They are also found to 
assist the chromatin remodeling by catalyzing ATP-dependent replacement of H2A-H2B histone polymers 
in nucleosomes (Jin et al., 2005). The third role is transcription regulation. RNA polymerase II 
holoenzyme complex and many transcription factors are found to interact with RUVBL1 and RUVBL2 for 
transcription regulation of many genes, like β-catenin (Bauer et al., 2000), c-Myc (Wood et al., 2000), and 
ATF2 [RUVBL2 only, (Cho et al., 2001)]. RUVBL1 and RUVBL2 regulate T-cell factor (TCF)-mediated 
transcription through β-catenin in Wnt signal pathway (Bauer et al., 2000). RUVBL proteins are also found 
to be related to cancer development through affecting the activity of transcription factors, such as β-
catenin and c-Myc (Cole, 1986). In addition, RUVBL proteins can also regulate cell apoptosis through 
Myc and E2F1. Lastly, RUVBL proteins contribute to the assembly and maturation of small nucleolar 
ribonucleoprotein (snoRNP) in the nucleoplasm. RUVBL2 is found to be present in the precursor 
complex, while RUVBL1 is associated with the maturing snoRNP complex (Watkins et al., 2004b). 
    In this present study, we identified RUVBL2 as the interacting partner of NS1 and demonstrated that 
influenza viruses reduced RUVBL2 expression to induce cell apoptosis in the absence of IFNs, while NS1 




Materials and Methods 
Cell Culture and Virus Infection. A549 cells, 293T cells and African green monkey kidney Vero cells 
were purchased from ATCC (Manassas, VA) and cultivated in DMEM medium supplemented with 10% 
FBS and 1% penicillin and streptomycin. NS1-deleted (delNS1) influenza A/PR/8/34 H1N1 virus was 
kindly provided by Adolfo Garcia-Sastre (Mount Sinai School of Medicine, NY), propagated and titrated in 
Vero cells as described previously (Wang et al., 2012). Wide-type (WT) influenza A/PR/8/34 H1N1 virus 
was cultured and titrated as described in Chapter 1.  
Two-dimensional Gel Electrophoresis (2-DE) and MS Analysis. As described in Chapter 2, we used 
2-DE based proteomic approach and mass spectrometry to identify cellular proteins that interact with 
NS1. RUVBL1 or RUVBL2 were among of those identified cellular proteins. 
Mammalian Two-hybrid Analysis and Reciprocal Co-IPs. RUVBL1 gene (GenBank accession no. 
NM_003707.2) and RUVBL2 gene (GenBank access no. CR533507) was amplified from a human 
genome library and inserted into an AD contained pVP16 vector for mammalian two-hybrid assay as 
described in Chapter 2. The cDNAs of RUVBL1 and RUVBL2 were also inserted into HA tagged pCruz 
vector for reciprocal co-IPs as described in Chapter 2. 
RNA interference (RNAi) and Overexpression. Two RUVBL2 specific siRNAs, 5’-
GAGACCAUCUACGACCUGGGCAC-3’ and 5’-GAGAGUGACAUGGCGCCUGUCCU-3’ (Watkins et al., 
2004a), were co-transfected into Vero cells for RNAi as described previously (Wang et al., 2012). 
RUVBL2 cDNA was inserted into pcDNA3.1 vector to generate pcDNA3.1-RUVBL2. For RUVBL2 
overexpression, the plasmid of pcDNA3.1-RUVBL2 was trans-transfected into Vero cells using 
Lipofectamine LTX with PLUS (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions.  
Western Blotting. Western blotting was conducted as described previously (Wang et al., 2012). 
Antibodies of anti-RUVBL1, anti-β-actin and anti-Annexin I were purchased from Santa Cruz Biotech 
(Santa Cruz, CA); antibodies of anti-RUVBL2 and anti-PARP were from BD (San Jose, CA).  
Caspase 3/7 Assay. Cell apoptosis was examined by Caspase-Glo 3/7 kit (Promega, Madison, WI) 
according to the manufacturer's instructions. Briefly, the treated Vero or A549 cells (3 treated and 1 




kit) at room temperature for 1 h, followed by luminescence detection in a spectrofluorometer 
(SPECTRAmax GEMINI XS, Molecular Devices). We repeated this analysis three times.  
Pre-treatment of Vero cells with IFN-α. After Vero cells were seeded into 6-well plates for overnight, the 
culture medium was replaced with fresh DMEM supplemented with 10% FBS and recombinant human 
IFN-αA/D (rHuIFN-αA/D; PBL Biomedical Labs, Piscataway, NJ) at 1,000 units/ml (Carlos et al., 2005; Yi 
et al., 2011). After 6 h incubation, cells were infected by delNS1 or WT viruses at an MOI of 1 and 






Identification of RUVBL1 and RUVBL2 as NS1 Interacting Proteins. Through a 2-DE-based proteomic 
approach described in Chapter 2, we identified the RUVBL1 and RUVBL2 proteins as the NS1 binding 
partners. To validate the interactions between NS1 and RUVBL1 or RUVBL2, reciprocal co-IPs and 
mammalian two-hybrid screening were conducted as described in Chapter 2. As shown in Fig. 1A, 
immobilized anti-Flag antibodies precipitated greater amount of RUVBL1 (right) or RUVBL2 (left) from the 
cells co-transfected with the plasmids that express Flag-NS1 and HA-RUVBL1 or HA-RUVBL2, 
respectively, but precipitated much less amount of proteins from the cells co-transfected with the plasmids 
that express Flag alone and HA-RUVBL1 or HA-RUVBL2. Similarly, in a reciprocal IP, immobilized anti-
HA antibodies precipitated greater amount of Flag-NS1 from the cells co-transfected with the plasmids 
that express Flag-NS1 and HA-RUVBL1 or HA-RUVBL2 (RUVBL1 on the right and RUVBL2 on the left in 
Fig. 1B), but failed to do so from the cells co-transfected with the plasmids that express HA tag alone and 
Flag-NS1 (Fig. 1B). To further test whether the interactions occur in vivo in cells, we performed 
mammalian two-hybrid assay. We observed that co-transfection of 293T cells with the Gal4 GFP reporter 
plasmid and the constructs encoding fusion proteins of BD-NS1 and AD-RUVBL1 or AD-RUVBL2 
resulted in higher expression of GFP than the negative control, in which BD and AD were fused with two 
proteins that are known to not interact, and protein pair of NS1-RUVBL2 induced higher expression of 
GFP than protein pair of NS1-RUVBL1 (Fig. 1C). These results suggest that NS1 is associated with 
RUVBL complex, especially RUVBL2 in human cells.  
Influenza Viruses Reduce RUVBL2 Expression While NS1 Inhibits Virus-induced Expression 
Reduction of RUVBL2. In order to study the role of the interactions between NS1 and RUVBL1 or 
RUVBL2, we first mock-infected or infected A549 cells with WT influenza A/PR/8/34 H1N1 virus at MOIs 
of 0.02, 0.075 and 0.3. We found RUVBL2 expression was dramatically reduced by virus infection (Fig. 
2A), but RUVBL1 expression was barely changed (data not shown). We further infected Vero cells with 
either WT or delNS1 influenza A/PR/8/34 H1N1 virus strains at the same initial amount. NS1 deletion in 
delNS1 virus-infected cells was confirmed by Western blotting with anti-NS1 antibody (4th row in Fig. 2B). 
We found RUVBL2 expression was reduced by both types of viruses in Vero cells from the early stage 




virus at 24, 36, and 48 hpi (Fig. 2B). Fig. 2C showed RUVBL1 expression was also reduced by both types 
of viruses at the late stage (48 hpi), but not 24 (data not shown) or 36 hpi, and its expression level in 
delNS1 virus-infected cells was lower than that in WT virus-infected cells at 48 hpi. These data suggest 
that (1) the virus induces an earlier expression reduction of RUVBL2 than RUVBL1; (2) other viral 
element(s), but not NS1, causes RUVBL2 expression reduction, while NS1 inhibits this virus-induced 
RUVBL2 reduction through the interaction.  
Influenza Virus Modulates Host Cell Apoptosis through RUVBL2 in Vero Cells. To examine the 
biological consequence of virus-induced RUVBL2 reduction, we used RNAi technique to knockdown 
endogenous RUVBL2 expression and examine the effect of reduced expression of RUVBL2 on viral NS1 
protein expression, virus replication and host cell apoptosis. The results demonstrated that silencing of 
RUVBL2 by siRNAs had no significant effects on viral NS1 protein expression and virus replication (data 
not shown). However, silencing of RUVBL2 by siRNAs induced cell apoptosis as evidenced by PARP 
cleavage (Fig. 3A), which is consistent with the report of Rousseau etc (Rousseau et al., 2007). We then 
performed the same experiments as Fig. 2B and examined cell apoptosis. We found that virus infection 
reduced RUVBL2 expression and induced apoptosis, evidenced by PARP cleavage (Fig. 3B) and 
caspase 3/7 activities (Fig. 3C) in Vero cells (the values of fold change for WT virus-infected cells were 
2.86 ± 0.24, 5.17 ± 0.19 and 5.54 ± 1.07, and for delNS1 virus-infected cells were 5.37 ± 0.04, 6.49 ± 1.63 
and 5.1 ± 0.92 at 24, 36 and 48 hpi, respectively). Fig. 3B,C also indicated that the greater expression 
reduction of RUVBL2 induced by delNS1 virus generally led to greater PARP cleavage and caspase 3/7 
activities than the less reduction of RUVBL2 induced by WT virus, which suggests that influenza viruses 
may induce cell apoptosis by reducing RUVBL2 expression in Vero cells. In order to verify this, we 
overexpressed RUVBL2 expression followed by virus infection and observed that when RUVBL2 was 
overexpressed in Vero cells, RUVBL2 expression was still reduced to a lower level by viruses, but cells 
with RUVBL2 overexpression had higher resistance to virus-induced apoptosis than cells without 
RUVBL2 overexpression infected with same kind of virus (the luminescence value reflects caspase 3/7 
activities in Fig. 3D). The data suggest that influenza virus reduces RUVBL2 expression to induce Vero 




IFNs Inhibit Apoptosis Regulated by the Virus-induced RUVBL2 Reduction. Even RUVBL2 
expression was reduced by virus in A549 cells (Fig. 2A), but when we performed the same experiments 
as Fig. 3B and C in A549 cells, the apoptosis (evidenced by PARP cleavage and caspase activities) was 
insignificant altered by both types of viruses (Fig. 4A,B). The different apoptosis response to virus 
infection in A549 cells suggested that the type Ι IFNs might inhibit apoptosis induced by the virus-induced 
RUVBL2 reduction. In order to verify the role of IFNs, we pre-treated Vero cells with recombinant 
universal human IFN-alpha, followed by delNS1 or WT virus infection for different time. We found that 
RUVBL2 expression was still reduced by both delNS1 and WT viruses at 36 and 48 hpi (Fig. 4C), but 
PARP cleavage (data not shown) and caspase 3/7 activities (Fig. 4D) were barely affected in virus-
infected Vero cells with pre-treatment of IFN, which was consistent to the observation in A549 cells (Fig. 
4A,B). This result contrasted sharply with what was observed in Vero cells without IFN pre-treatment 
shown in Fig. 3B and C, which demonstrated that PARP cleavage and caspase 3/7 activities were 
significantly increased when RUVBL2 expression was reduced by virus. In other words, the different 
results between Fig. 3C and 4D demonstrated that type Ι IFNs counteract cell apoptosis induced by the 






    In this present study, we found that RUVBL1 and RUVBL2, RUVBL2 in particular, are important 
interaction partners of influenza viral protein NS1. We verified the interactions by reciprocal co-IPs (Fig. 
1A,B) and mammalian two-hybrid assay (Fig. 1C). Mammalian two-hybrid assay showed the greater 
expression of reporter GFP induced by the interaction of RUVBL2 and NS1 than that induced by RUVBL1 
and NS1 interaction, and the further function studies demonstrated that virus-induced change in 
expression of RUVBL2 occurred prior to RUVBL1, suggesting RUVBL2 is more directly relative to both 
influenza virus and viral NS1, and the interaction between RUVBL1 and NS1 might be bridged by 
RUVBL2 (Fig. 5).  
    The fact that delNS1 viruses induced more pronounced expression reduction of RUVBL2 than WT 
viruses suggests there is viral element(s) responsible for the RUVBL2 reduction while NS1 increases 
RUVBL2 level by inhibiting the virus-induced expression reduction of RUVBL2 through the interaction. 
Three RNA polymerase subunits encoded by influenza virus genes, PB1, PB2 and PA, together with 
nucleoprotein (NP) and viral RNAs form the viral ribonucleoproteins (vRNPs). Since RUVBL2 was 
reported to interact with vRNPs (Kakugawa et al., 2009; Mayer et al., 2007) to inhibit virus replication 
(Kakugawa et al., 2009) and NS1 protein was reported to interact with vRNPs gene (Wang et al., 2008), 
we hypothesized that the influenza vRNPs may be responsible to reduce RUVBL2 expression for 
eliminating the virus replication inhibitors (Fig. 5). Consider the effect on cell apoptosis, viral vRNPs may 
play a pro-apoptotic role by reducing RUVBL2 expression while viral NS1 may play an anti-apoptotic role 
by increasing RUVBL2 level. The opposite roles of different influenza viral components on apoptosis 
regulation may explain why current findings about NS1 effects on apoptosis conflict (Ehrhardt et al., 2007; 
Zhang et al., 2011a).   
     For the pathway utilized by RUVBL2 to regulate apoptosis, it was reported that the expression of pro-
apoptotic factor, BAD, was increased significantly when RUVBL2 was silenced by RNAi (Rousseau et al., 
2007). PI3K pathway is found to inhibit apoptosis by activating PI3K effector AKT, which in turn 
phosphorylates and inactivates pro-apoptotic proteins like BAD (Igney and Krammer, 2002). AKT has one 
substrate named AS160, which was reported to interact with RUVBL2 (Xie et al., 2009). So based on 




via the interaction with AS160. Moreover, influenza NS1 was reported to inhibit apoptosis by binding to 
PI3K (Ehrhardt et al., 2007a) and the activated AKT (Matsuda et al., 2010). Taken together, NS1 plays 
anti-apoptotic roles through the PI3K/AKT pathway by either activating survival signal AKT (Matsuda et 
al., 2010) or increasing RUVBL2 level via inhibiting vRNPs-induced expression reduction (Fig. 5).  
    Type I IFNs (IFN α, β, ε, κ and ω) as multifunctional cytokines are essential for host innate immune 
responses against viruses, bacteria, protozoal, and cancer. They bind to a common receptor consisting of 
IFNAR1 and IFNAR2 chains to activate several downstream pathways and one of them is PI3K/AKT 
pathway. IFNs can activate PI3K/AKT to protect cells against pro-apoptotic signals by recruiting the 
regulatory subunit p85 of PI3K to IFNAR complex and then tyrosine-phosphorylating it (Ruuth et al., 2001; 
Yang et al., 2001). So the regulation of apoptosis by IFNs also through PI3K/AKT pathway supplies the 
possibility to explain that the apoptosis induced by the RUVBL2 reduction only occur in the absence of 
IFNs. The reduction of RUVBL2 expression decreases AKT expression or reduces AKT activity with 
consequence of apoptosis induction, while the survival signals from IFNs increase AKT expression or 
enhance AKT activity with consequence of apoptosis inhibition (Fig. 5), and the modulation on apoptosis 
by IFNs overwhelms the regulation induced by the RUVBL2 reduction. For the real virus infection 
surroundings with IFNs presence in infected cells, it is also possibly that influenza virus may regulate cell 
apoptosis through RUVBL2, since the virus has evolved to employ several strategies to suppress IFN 
production as described in Background section and Chapter 1.  
    We also found that knockdown of RUVBL2 by siRNA increased apoptosis in A549 cells (data not 
shown), which is consistent with the reported results (Rousseau et al., 2007). But it does not conflict to 
our present finding that virus-induced RUVBL2 reduction only induces apoptosis in absence of IFNs. 
Virus infection brings pathogen characters, like viral dsRNA, which are immediately recognized by host 
immune system to trigger immune defenses, such as IFN secretion in IFN-competent cells, while siRNAs 
for RNAi usually do not trigger much immune response. So this difference might explain that siRNA-
induced RUVBL2 reduction can increase apoptosis in IFN-competent cells while virus-induced RUVBL2 
reduction can not, which is consistent with the our explanation mentioned in last paragraph.  
    Besides RUVBL2 effect on host cell apoptosis, RUVBL1 is also reported to be involved in apoptosis 




al., 2002), which mainly depends on the activity of p53 (Hermeking and Eick, 1994), Fas/FasL (Hueber et 
al., 1997) or Bax (Eischen et al., 2001), as illustrated in Fig. 5. It is possibly that RUVBL1 is an alternative 
target for influenza virus to regulate host cell apoptosis.  
    Based on our findings and other reports, we hypothetically constructed a pathway model to explain the 
relationships of influenza virus protein NS1, vRNPs, cellular RUVBL1/RUVBL2 and IFNs with protein 
complex effect on regulation of cell apoptosis (Fig. 5). However, some hypotheses among this pathway 
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appropriate time were analyzed by Western blotting with antibodies to anti-RUVBL2 and anti-NS1 (B) or 
anti-RUVBL1 (C). Annexin-1 was used as a loading control. This experiment has been independently 
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The NS1 protein of influenza virus plays various roles through interacting with cellular proteins. In this 
study, we used two-step affinity precipitations to verify an interaction between a DDX isoform (we 
designated it here as DDX100) and influenza virus protein NS1, which was previously identified through a 
more sensitive proteomic method called SILAC (stable isotope labeling with amino acids in cell culture). 
Knockdown of DDX100 by small interfering RNA (siRNA) resulted in decreased synthesis of NS1 viral 
RNA and NS1 mRNA in the virus-infected cells. Concomitantly, we performed in vivo and in vitro 
experiments to demonstrate that DDX100 plays a helicase role in influenza viral NS1 dsRNA and NS1 
recruits DDX100 to assist viral NS1 dsRNA unwinding. In addition, we showed that siRNA-mediated 
knockdown of DDX100 leads to reduced expression of NS1 protein and virus replication. Lastly, we 
screened other cellular proteins in NS1-DDX100 complex by a two-step affinity precipitation-based 
proteomic approach and mass spectrometry, and found that most of identified proteins shared the same 
function in mRNA maturation, suggesting the interaction between NS1 and DDX100 may affect mRNA 
maturation. Our results suggest that the interaction between NS1 and DDX100 contributes to the 
replication of influenza virus in host cells potentially through facilitating NS1 gene replication, transcription, 
and viral dsRNA unwinding, which provides valuable information for designing novel antiviral therapy in 
the future. 





    The DEAD-box family was named based on the nine conserved motifs with the second motif containing 
four amino acids sequence Asp-Glu-Ala-Asp (D-E-A-D). Many different protein members of DEAD-box 
family exist in eukaryotes but very few in prokaryotes (Linder, 2006). More than 500 proteins are found to 
carry the DEAD-box characterizes (Silverman et al., 2003). Twenty-five DEAD-box proteins are identified 
in yeast Saccharomyces cerevisiae (de la Cruz et al., 1999) and thirty-eight DEAD-box proteins with 
subfamilies (DDX1-6, 10, 17-21, 23-25, 27-28, 31, 39, 41-43, 46-56, 59 and BAT 1) identified in human 
(Linder, 2006). In contrast, only a few of DEAD-box proteins is found in bacteria and some bacterial 
genomes even do not encode DEAD-box proteins at all (Iost and Dreyfus, 2006). DEAD-box family is 
often referred to DExD/H proteins together with its two relative families, DEAH and the Ski (de la Cruz et 
al., 1999), since they share eight conserved motifs (Tanner and Linder, 2001). But they also can be 
distinguished by variations with their unique conserved motifs (Cordin et al., 2006).   
    DEAD-box family, the biggest family among DExD/H proteins, play roles in nearly every aspect of RNA 
processing, like RNA-binding, unwinding, annealing, translation initiation, maturation and decay (Cordin et 
al., 2006; Fuller-Pace, 2006; de la Cruz et al., 1999). One of the common functions of the DEAD-box 
proteins is ATP-dependent RNA helicase since the typical DEAD-box protein contains an essential 
helicase core distributed between N and C terminals. The protein-binding domain of DEAD-box protein 
mediates the helicase role by nonspecifically binding to dsRNA and then inducing RNA conformational 
changes in an ATP-dependent manner. DDX100 belongs to the DEAD-box family and expresses in all 
mammalian cell types in either nucleus or cytoplasm depending on the cell type (Edgcomb et al., 2012). 
DDX100 functions in several host cell processes, like RNA metabolism (Godbout et al., 1998), RNA 
transcription (Ishaq et al., 2009), mRNA translation (Kanai et al., 2004), protein interaction and enzymatic 
activity. DDX100 was reported to contribute to the HIV viral replication (Edgcomb et al., 2012). 
    In this present study, we showed that the interaction between DDX100 and influenza virus protein NS1 
was required for viral NS1 gene replication, transcription, translation, viral dsRNA unwinding and whole 
virus replication. In addition, identifying other cellular proteins in the NS1-DDX100 complex suggested 





Materials and Methods 
Cell Culture, Virus Infection and Proteome Labeling. A549 cells, 293T cells, Vero cells and MDCK 
cells were cultivated in DMEM medium supplemented with 10% fetal bovine serum and 1% penicillin and 
streptomycin. Influenza A/PR/8/34 H1N1 viruses were propagated and titrated as described (Wang et al., 
2012).  
Plasmid DNA Construction and Transfection. Flag tagged NS1 plasmid was constructed as described 
previously (Wang et al., 2012). NS1 cDNA was also amplified and inserted into pcDNA3.1 vector without 
tags. DDX100 cDNA was amplified from a human genome library and inserted into BamH I and Xho I 
sites of pcDNA3.1 vector with a TAP tag at N terminal (NTAP) to generate the plasmid of pcDNA3.1-
NTAP-DDX100 for two-step affinity precipitations. DDX100 cDNA was also inserted into pcDNA3.1 vector 
with Flag tag to generate the plasmid of pcDNA3.1-2F-DDX100 for dsRNA unwinding experiments. 
Expression plasmids were confirmed by DNA sequencing and then transiently transfected into 293T cells 
with the standard calcium phosphate method.  
Western Blotting. Western blotting was conducted as described (Wang et al., 2012) and rabbit anti-
DDX100 polyclonal antibody was purchased from Santa Cruz Biotech (Santa Cruz, CA). 
Two-step Affinity Precipitations. NTAP tagged plasmid of pcDNA3.1-NTAP-DDX100 and Flag tagged 
plasmid of pcDNA3.1-2F-NS1 were co-transfected into 2 billion of 293T cells. Cells were lysed and 
precipitated by M2 resin to enrich Flag-NS1 in first step affinity precipitation as described in Chapter 2. 
NaCl concentration in precipitated Flag-NS1 complex was diluted by water to 150 mM. In the second step 
affinity precipitation, IgG beads that specially bind to TAP tag were used to precipitate NTAP-DDX100 
from the first step precipitated Flag-NS1 complex for 4 h at 4°C. After being washed for 4-8 times by TEV 
buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 0.1% NP-40, 1 mM DTT), the precipitated 
IgG beads were incubated with acTEV enzyme in 16 °C  water bath for 2 h to cleave NTAP, followed by 
rotation for overnight at 4 °C. The supernatant con taining cleaved NTAP-DDX100 and its bound proteins 
was collected by centrifugations. After two-step immunoprecipitations, the NS1-DDX100 protein complex 
was either purified by sucrose gradient ultracentrifugation (13 ml) or detected by Western blotting with 
antibodies of anti-DDX100 and anti-Flag to validate the interaction between NS1 and DDX100. For 




detected by Western blotting with antibodies of anti-DDX100 and anti-Flag. The layers containing NS1 
and DDX100 were subjected to a desalted process by NAT-25 column (GE, Pittsburgh, PA), followed by 
the separation on a SDS-PAGE gel and protein identification by MS as described (Wang et al., 2012).  
RNAi. One siRNA fragment (5’-CAAGCCCUCUUUCCUGCCUGUUU-3’) targeting DDX100 was 
designed. A randomized siRNA sequence was used as a control. The siRNA transfection into cells was 
performed with Lipofectamine TM RNAiMAX as described (Wang et al., 2012). 
Plaque Assay. Plaque assay to detect virus replication titer was conducted as described (Wang et al., 
2012). 
qRT-PCR. The levels of IFN-α/β mRNA in cells, NS1 mRNA and NS1 vRNA were detected by qRT-PCR 
as described in Chapters 1 and 2.  
Viral dsRNA Synthesis and Detection by Immunoblotting. Viral NS1 dsRNA was synthesized using 
Ambion MEGAscript RNAi kit (Grand Island, NY) according to manufacture’s instruction. Briefly, NS1 
cDNA was amplified using a pair of primers with T7 promoter at each end (forward: 5’- 
TAATACGACTCACTATAGGGATGGATCCAAACACTG-3’ and reverse: 5’- 
CCCTATAGTGAGTCGTATTATCAAACTTCTGACC-3’). When PCR was used to amplify NS1 with T7 
promoters, the annealing temperature in first five cycles was set up based on NS1 specific primer Tm, 
and the rest cycles based on whole primer Tm. Agarose electrophoresis was used to identify and purify 
the target band. Then four ribonuclotide solutions (ATG, CTP, GTP, UTP), reaction buffer and T7 RNA 
polymerase (all supplied in the kit) were mixed together with template (total 20 µl) and incubated at 37 °C 
for overnight. Since the NS1 fragment is short (<800bp), two ssRNA can anneal together to generate 
dsRNA after synthesis without extra annealing process. On the next day, both DNase and RNase (all 
supplied in the kit) were added to dsRNA mixture to cleave DNA and unannealed RNA (dsRNA can not 
be cleaved by the supplied RNase), followed by purification on the supplied column. UV spectrometer 
was used to detect the dsRNA absorbance at 260nm and dsRNA concentration was calculated by A260 × 
10 (dilution fold) × 40 (µg/ml). dsRNA was confirmed by agarose electrophoresis with a dsRNA size 
marker and the following immunoblotting with anti-dsRNA J2 antibody.  
    The synthesized dsRNA transfection into Vero cells was carried out by the standard calcium phosphate 




isolated from cells and then loaded onto 5% native gel (Non-denature PAGE gel) with a dsRNA marker. 
Electrophoresis was run at 120V for 1 h (6 × 9 cm gel), followed by semi-dry transfer to positively charged 
Nylon membrane (Nytran SPC, Whatman) (Polvino et al., 1983) at 250 mA for 1 h. Then the membrane 
was blocked by 5% non-fat dry milk in TBS for 30 min, followed by incubation with mouse anti-dsRNA J2 
antibody (Engscicons, Hungary) diluted by 500 fold in 5% milk with 0.1% (v/v) Triton X-100 diluted in TBS 
for overnight at 4°C. Mouse J2 monoclonal antibody can specially recognize the secondary structure of 
dsRNA with greater than 40 bp. After being washed, membrane was further incubated with rabbit anti-
mouse second antibody conjugated with HRP for 1 h. The target dsRNA bands were developed with 
SuperSignal West Femto Chemiluminescent Substrate (Thermo, San Jose, CA). After development, the 
membrane was further stained with methylene blue solution [0.02% (wt/vol) in 0.3 M sodium acetate, pH 
5.5] to observe 18S ribosomal subunit as the convenient size marker (1.9 kb) and loading reference.    
Biotin UTP Labeled dsRNA Synthesis and Detection. NS1 cDNA was inserted into Xba Ι and Sac Ι 
sites of pSP64/poly (A) vector (Promega, Madison, WI), which contains SP6 promoter at the 5’ terminal 
and a 33 nt poly (A) tail at the 3’ terminal (Chen et al., 2002). The plasmid was then linearized with EcoR Ι 
and transcribed by SP6 RNA polymerase to generate one NS1 ssRNA. NS1 cDNA was also amplified 
with a pair of primer with T7 promoter on the reverse primer (forward: 5’-ATGGATCCAAACACTG-3’ and 
reverse: 5’- CCCTATAGTGAGTCGTATTATCAAACTTCTGACC-3’). The amplified NS1 cDNA fragment 
with T7 promoter at the 3’ terminal was transcribed by T7 RNA polymerase with substrate of Biotin-11-
UTP (Ambion) to generate an complementary NS1 ssRNA labeled with biotin UTP. Two ssRNAs were 
annealed to generate biotin UTP labeled NS1 dsRNA by heating two ssRNA mixture to 75°C for 5 min 
and cooling down to room temperature for overnight. After treated with DNase and RNase as described 
above, the synthesized biotin UTP labeled dsRNA was confirmed by immunoblotting with anti-dsRNA J2 
antibody and streptavidin described in the following.  
    dsRNA unwinding assay was performed as described (Chen et al., 2002). Briefly, DDX100 was 
enriched by anti-Flag M2 resin from 293T cells transfected with Flag-DDX100 plasmid or co-transfected 
with plasmids of Flag-DDX100 and non-tagged NS1. Biotin UTP labeled NS1 dsRNA (500 ng) was 
incubated in a 10 µl reaction containing 17 mM HEPES, pH 7.5, 150 mM KCl, 2 mM DTT, 1 mM MgCl2, 




of precipitated DDX100 (attached on M2 resin, not eluted) at 37 °C for 20 min. Two µl of termination 
buffer (1 mg/ml proteinase K, 5% SDS) was then added to terminate the reaction and further incubated 
for 15 min. The unwinding reaction mixture was loaded onto a 5% native gel, followed by semi-dry 
transfer as described above. The membrane was blocked by Odyssey Blocking Buffer (LI-COR, Lincoln, 
NE) with 1% SDS for 30 min, followed by incubation with IRDye 800CW Streptavidin (LI-COR) diluted by 
10,000 fold in the same blocking buffer for another 30 min. After being washed by PBS, the membrane 





Identification and Confirmation of Interaction between DDX100 and NS1. A more sensitive 
quantitative proteomic method, SILAC, was used to identify cellular proteins that interact with NS1 and 
DDX100 was one of identified proteins (Lin Liu’s work). To confirm the interaction between DDX100 and 
NS1, we used two-step affinity precipitations: immobilized anti-Flag M2 resin was first used to precipitate 
Flag-NS1 complex from 293T cells co-transfected with NTAP-DDX100 and Flag-NS1 plasmids; and 
immobilized anti-NTAP IgG beads were then used to precipitate NTAP-DDX100 from the first step 
precipitated Flag-NS1 complex. The precipitated protein complexes from sequential precipitations were 
subjected to Western blotting with antibodies to anti-DDX100 and anti-Flag. Fig. 1 showed that 
immobilized anti-Flag M2 resin with Flag-NS1 complex  (upper left) precipitated large amount of NTAP-
DDX100 (lower left) from cells co-transfected with NTAP-DDX100 and Flag-NS1 plasmids in the first step 
precipitation. In the second step precipitation, immobilized anti-NTAP IgG beads with DDX100 complex 
(lower right) precipitated large amount of Flag-NS1 (upper right) from the first step precipitated Flag-NS1 
complex. Besides, IPs and immunofluorescence to detect the colocalization were also conducted to 
validate the interaction between NS1 and DDX100 (Lin Liu’s results). These data suggest that NS1 
interacts with DDX100 in human cells.  
DDX100 Promotes NS1 Protein Expression in the Virus-Infected cells. To determine the potential 
roles of the interaction between DDX100 and NS1, we silenced the expression of endogenous DDX100 
by siRNAs in A549 cells and then examined the effect of the DDX100 silencing on NS1 protein 
expression in the virus-infected cells. The results demonstrated that when the expression of DDX100 was 
silenced by siRNA (Fig. 2; upper row), viral NS1 protein expression decreased (Fig. 2; middle row), 
suggesting that DDX100 is required for viral NS1 protein expression in the virus-infected cells.  
DDX100 Promotes NS1 vRNA Replication and mRNA Transcription, but does not Affect NS1 mRNA 
Nuclear Export. To elucidate the mechanism by which DDX100 promotes viral NS1 protein expression in 
the virus-infected cells, we examined the effect of knockdown of DDX100 expression on NS1 gene 
replication (vRNA) and transcription (mRNA) in the virus-infected A549 cells using qRT-PCR as described 
in Chapter 2. We found the knockdown of DDX100 decreased NS1 vRNA levels by 66% (0.34 ± 0.08) and 




Similarly, knockdown of DDX100 decreased NS1 mRNA levels by 40% (0.6 ± 0.08) and 66 % (0.34±0.02) 
at 8 hpi and 12 hpi, respectively compared with those levels in non-silenced cells (Fig. 3B).  
These results suggest that DDX100 promotes both viral NS1 gene replication and transcription in the 
virus-infected cells. Nucleo-cytoplasmic translocation of mRNA affects mRNA transcription. To examine 
whether the effect of DDX100 on NS1 mRNA transcription results from the effect of DDX100 on NS1 
mRNA nucleo-cytoplasmic translocation, we used a differential-centrifugation-based method to fractionate 
the lysates of DDX100 silenced or non-silenced cells into cytoplasmic and nuclear parts, followed by 
measuring NS1 mRNA distribution in cytoplasmic and nuclear parts by qRT-PCR as described in Chapter 
2. We found that when DDX100 expression was knocked down, the ratio of NS1 mRNA distribution in 
nucleus to cytoplasm altered insignificantly (data not shown), suggesting that DDX100 does not affect 
viral NS1 mRNA nuclear/cytoplasmic trafficking.  
DDX100 Unwinds Viral NS1 dsRNA. Helicase activity is the major function of DEAD family. Influenza 
virus genome does not encode helicase but the virus requires viral dsRNA to be unwound (Wisskirchen et 
al., 2011). So influenza virus must utilize host machinery to unwind viral dsRNA and we hypothesized 
DDX100 may be one of host machinery for viral dsRNA unwinding. To prove that, we first synthesized 
one viral dsRNA in vitro based on NS1 sequence, since the native influenza viral dsRNA is undetectable 
by the immunoblotting with anti-dsRNA J2 antibody (data not shown) or immunofluorescence (Weber et 
al., 2006). The synthesized NS1 dsRNA contains biotin UTP on one strand of RNA and a poly (A) tail on 
another strand of RNA, which is required for DDX100 unwinding in vitro (Chen et al., 2002). We first used 
the immobilized anti-Flag M2 resin to enrich DDX100 protein from 293T cells transfected with Flag-
DDX100 plasmid, and then incubated the increased amount of precipitated DDX100 with biotin UTP 
labeled NS1 dsRNA in vitro. We found that as the increase in DDX100 amount, more dsRNA was 
unwound to ssRNA in vitro (Fig. 4A). To verify the helicase role of DDX100 in vivo, we mock-treated or 
treated Vero cells with DDX100 specific siRNAs, followed by introduction of NS1 dsRNA [no biotin UTP 
and poly (A) tail] into cells. NS1 dsRNA was examined by immunoblotting with anti-dsRNA J2 antibody 
and the intensity of 18s rRNA was considered as the loading control. As shown in Fig. 4B, the band 
intensity of NS1 dsRNA isolated from DDX100 silenced cells was significantly higher than that from 




helicase role of DDX100 in vivo. Viral dsRNA is known to activate host protein kinase R (PKR) and further 
NF-κB, which initiates the transcription of IFN-β (Lu et al., 1995; Wang et al., 2000). To further validate 
the helicase role of DDX100 in viral dsRNA in vivo, IFN-α/β transcriptions were examined. A549 cells 
were mock-treated or treated with DDX100 specific siRNA, followed by infection of influenza virus at an 
MOI of 2 for 8 and 12 h. qRT-PCR showed the silencing of DDX100 increased IFN-β mRNA levels by 1-3 
folds (2.88 ± 0.33 and 1.75 ± 0.23 at 8 hpi and 12 hpi, respectively) (Fig. 5) but not IFN-α (data not 
shown), suggesting that higher level of dsRNA resulted from DDX100 knockdown triggers more IFN-β 
secretion. Our data suggest that DDX100 plays a helicase role in viral NS1 dsRNA unwinding.  
NS1 Recruits DDX100 for Viral dsRNA Unwinding. Viral dsRNA is a pathogen character that can easily 
be recognized by the host immune system to trigger immune defenses, so the virus evolves mechanisms 
to eliminate the effect of dsRNA on host cell immune response. Influenza virus NS1 was reported to 
competitively bind to viral dsRNA against PKR activation (Wang et al., 2000). So after we knew the 
helicase role of DDX100, we hypothesized that the interaction between NS1 and DDX100 may promote 
viral dsRNA unwinding. To verify this, we first precipitated DDX100 from cells co-transfected with 
plasmids of Flag-DDX100 and non-tagged NS1 or plasmid of Flag-DDX100 alone as control by 
immobilized anti-Flag M2 resin. After quantify and equal the concentration of DDX100 precipitated from 
cells with or without NS1 expression, we incubated the increased amount of precipitated DDX100 with 
biotin UTP labeled NS1 dsRNA substrate and found the DDX100 precipitated from control cells required 
more than 7 fold higher amount to completely unwind dsRNA substrate than DDX100 precipitated from 
cells with NS1 expression (Fig. 6A), suggesting NS1 promotes DDX100 to unwind viral NS1 dsRNA in 
vitro.  To verify the effect of NS1 on DDX100 helicase activity in vivo, we repeated the experiment as Fig. 
4B except the introduction of NS1 plasmid rather than viral infection into DDX100 silenced cells. As 
shown in Fig. 6B, compared to DDX100 silence alone, the addition of NS1 dramatically reduced dsRNA 
level, suggesting NS1 promotes DDX100 to unwind viral dsRNA in vivo. Our data suggest that NS1 
promotes DDX100 helicase role in viral dsRNA unwinding. 
DDX100 Promotes Influenza Virus Replication. Since DDX100 affects influenza viral NS1 gene 
replication, transcription (Fig. 3), expression (Fig. 2) and viral dsRNA unwinding (Fig. 4), we speculated 




the A549 cells, the virus titers decreased significantly (Fig. 7), suggesting that DDX100 promotes 
influenza virus replication in the infected cells.  
Cellular Proteins in NS1-DDX100 Complex. In order to further explore the biological function of the 
interaction between NS1 and DDX100, we screened cellular proteins in the NS1-DDX100 complex by a 
two-step affinity precipitation-based proteomic approach coupled with MS. The plasmids of 2F-NS1 and 
NTAP-DDX100 were co-transfected into 2 billion of 293T cells, followed by NS1 and DDX100 enrichment 
as described above. The protein complex precipitated by both NS1 and DDX100 was further purified by 
gradient sucrose ultracentrifugation. After each layer of sucrose was examined by Western blotting with 
antibodies of anti-DDX100 and anti-Flag, the target layers were further separated by SDS-PAGE. 
Through MS analysis, we identified cellular proteins in NS1-DDX100 complex. Most of identified proteins 
shared the function in pre-mRNA maturation, a progress including splicing and addition of 5’-cap and 3’-
poly (A) tail onto pre-mRNA. hnRNP K is the major pre-mRNA binding protein and reported to interact 
with DDX100 (Chen et al., 2002). DDX5 plays the regulative role on pre-mRNA splicing (Kar et al., 2011). 
Polypyrimidine tract-binding protein 1 (PTB/hnRNP I) as the splicing regulator antagonizes exon definition 
with preferentially binding to pyrimindine-rich intronic silencers (Lin and Tarn, 2005; Wagner and Garcia-
Blanco, 2001). Polypyrimidine tract-binding protein-associated-splicing factor (PSF) was also identified. 
PSF is essential for the pre-mRNA splicing steps of intron release and exon ligation by regulating splice 
site selection (Gooding et al., 1998). TAR DNA-binding protein (TDP43) stabilizes mRNA through directly 
interacting with the 3’-untranslated region (3’UTR) (Strong et al., 2007). ELAV-like protein 1 
(ELAVL1/HuR) as the only ARE (AU rich-rich element)-binding protein functions in stabilizing mRNA 
containing ARE (Tran et al., 2003). In addition of proteins with function in pre-mRNA maturation, a tRNA 
ligase complex was identified to associate with NS1-DDX1 complex. UPF0027 protein C22orf28 
(HSPC117) as the only catalytic subunit together with FAM98, UPF0568 and C14orf166 in tRNA ligase 
complex (Popow et al., 2011) were all identified to associate with NS1-DDX100 complex, which increases 





    In this present study, the DEAD-box protein DDX100 was verified to interact with influenza virus protein 
NS1 and this interaction was required for influenza viral NS1 gene replication, transcription, translation, 
dsRNA unwinding and eventual whole virus replication. We found that NS1 recruited DDX100 for viral 
dsRNA unwinding, which not only promotes viral RNA replication, but also counteracts dsRNA-induced 
host cell immune defenses. Consider the significance of this interaction, we further screened other 
cellular proteins in NS1-DDX100 complex and found most of identified proteins shared the same function 
in pre-mRNA maturation, suggesting the interaction between NS1 and DDX100 may affect viral or cellular 
mRNA maturation.  
    The DEAD-box proteins were reported to contribute to virus replication in various viral systems through 
interactions with various viral proteins. HIV-1 Rev protein required for viral mRNAs nuclear/cytoplasmic 
trafficking and the generation of infectious HIV-1 virion was reported to associate with DDX100 to 
maintain the proper subcellular distribution of lentiviral regulatory protein (Fang et al., 2004). NS proteins 
of severe acute respiratory syndrome coronavirus (SARS-Cov) and infectious bronchitis virus (IBV) were 
reported to interact with DDX100 for the efficient virus replication in host cells (Xu et al., 2010). Besides 
DDX100, DDX3 was reported to assist hepatitis C virus (HCV) RNA replication by binding to HCV core 
protein (Ariumi et al., 2007) and play an enhancement role on HIV-1 RNA nuclear export (Yedavalli et al., 
2004). Thus, the beneficial roles of DEAD-box proteins, especially DDX100, in other viral systems boost 
the confidence of our findings in influenza viral system. 
    DDX100-induced increase in NS1 gene replication and transcription may result from the helicase effect 
of DDX100 on viral NS1 dsRNA unwinding. During influenza viral genome replication, the (-) strand 
genome RNAs serve as templates to synthesize the complementary intermediate RNA (cRNA) with a 
transient phase of dsRNA existence. Once dsRNA is broken down to one (-) strand and one (+) strand 
RNA, (-) strand vRNAs are assembled into new virions and (+) strand cRNAs are either served as the 
templates to replicate more (-) strand vRNAs or proceeded to generate viral mRNA with addition of 5' 
capped primer and 3' poly (A) tail. Our results about significant decrease in NS1 vRNA and mRNA in 




NS1 mRNA nuclear export, resulted from DDX100 depletion caused less release of both (-) and (+) 
strand RNAs.  
    There might be more than one pathway utilized by DDX100-dsRNA to induce type Ι IFNs. DDX100 was 
reported to sense dsRNA to activate type Ι IFN response through TRIF pathway (Zhang et al., 2011). 
PKR, also known as dsRNA-activated protein kinase, was reported to detect viral dsRNA to initiate IFNs 
transcription through NF-κB (Lu et al., 1995; Wang et al., 2000). Two pathways used by DDX100-dsRNA 
to induce type Ι IFNs may explain our result that the level of IFN-β not IFN-α was increased by virus 
infection when DDX100 expression was knocked down. Silencing of DDX100 expression increased freer 
viral dsRNA, which induces transcription of both IFN-β and IFN-α by PKR-NF-κB pathway, while, 
according to Zhang etc (Zhang et al., 2011), silencing of DDX100 should reduce DDX100 capability to 
sense dsRNA with the consequence of TRIF pathway inactivation. Since TRIF pathway is mainly utilized 
by TLR3/4 for IFN-α production (Richez et al., 2009), the inactivated TRIF pathway may lead to decrease 
in IFN-α transcription, which compromises the IFN-α level induced by the activated PKR pathway.  
    Viral dsRNA unwinding benefits both virus genome replication and virus escape from host immune 
recognition. The loss of dsRNA unwinding would expose dsRNA to be recognized by host immune 
system to trigger immune responses and one of triggered immune responses is IFN secretion. IFNs 
induce murine Mx1 protein, which inhibits influenza virus RNA replication and transcription (Broni et al., 
1990; Krug et al., 1985). IFNs also promote cytotoxic T cells to recognize virus by enhancing MHC Ι 
expression, activate NK cells to kill virus-infected cells or induce virus-infected cell apoptosis to limit virus 
infection. The loss of dsRNA unwinding would also decrease virus replication suggested by our results 
about significant decrease in NS1 gene replication and transcription induced by DDX100 silence (Fig. 3). 
So virus must evolve mechanism(s) to unwind viral dsRNA and DEAD-box family is likely one of the most 
potential candidates to take responsibility to unwind viral dsRNA. Besides the DDX100 present here, 
another DEAD-box family protein, UAP56, was reported to unwind influenza viral dsRNA through viral NP 
protein (Wisskirchen et al., 2011).  
    In summary, we found that the interaction between NS1 and DDX100 contributes to virus replication 
potentially through facilitating NS1 gene replication, transcription and viral dsRNA unwinding, which 




proteins in NS1-DDX100 complex suggests that the interaction between NS1 and DDX100 may affect 
pre-mRNA maturation, especially pre-mRNA splicing, and cellular tRNA ligation, which might be 
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General Discussion and Conclusion  
    In the present study, we first examined how protein expression in human lung epithelial cells 
responded to influenza virus infection at the proteome level by using a two-dimensional gel 
electrophoresis-based proteomic method. We found that the expression of IκB kinase-gamma (IKKγ) was 
suppressed by influenza A virus infection. Functional analyses suggest that IKKγ and influenza virus are 
mutually inhibitory, and influenza viruses may inhibit IFN production through suppressing the expression 
of IKKγ during viral infection. We then focused on identifying and characterizing novel cellular proteins 
that are associated with a key influenza vrial protein that is a major virulence factor and contributes 
significantly to pathogenesis – NS1. The first protein that was identified to interact with NS1 was 
heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1). Knockdown of hnRNP A2/B1 by siRNA 
resulted in increased synthesis of NS1 viral RNA and NS1 mRNA in the virus-infected cells. In addition, 
we found that hnRNP A2/B1 is associated with NS1 and NS2 mRNAs and siRNA-mediated knockdown of 
hnRNP A2/B1 promotes transport of NS1 mRNA from the nucleus to the cytoplasm in the infected cells. 
The results suggest that hnRNP A2/B1 plays an important inhibitory role in the replication of influenza A 
virus in host cells potentially through inhibiting NS1 gene replication, transcription, and NS1 mRNA 
nucleocytoplasmic translocation.  The second cellular protein that was identified to interact with NS1 was 
RUVBL2, and functional studies demonstrated that influenza viral protein NS1 may inhibit the apoptosis 
of the infected cells in the absence of IFNs through interacting, hence protecting cellular RUVBL2. The 
third protein that was identified to interact with NS1 was a DEAD-box family member, designated 
DDX100. We found that knockdown of DDX100 by siRNA resulted in decreased synthesis of NS1 viral 
RNA and NS1 mRNA in the virus-infected cells. More importantly, we found that NS1 inhibits IFN 
production through promoting the unwinding of viral dsRNAs via enhancing the helicase activity of 
DDX100.   
    The results from the present study revealed several novel mechanisms underlying the interactions 
between host cells and influenza viruses. At the same time, our results also raised some questions that 
need to be addressed in the future.  First, our results showed that hnRNP A2/B1 inhibits both viral NS1 
mRNA transcription and NS1 mRNA nuclear export, two molecular precesses that are closely related to 




two molecular processes or if hnRNP A2/B1 affects one of them and the other is a secondary change. 
Second, based on our results and published resutls, we hypothezied that vRNP complex may be 
responsible for suppressing the expression of RUVBL2 in the virus-infected cells. This postulation needs 
to be experimentally tested. Third, multiple cellular proteins functioning in mRNA maturation were 
identified to associate with the NS1-DDX100 complex, suggesting that NS1-DDX100 complex may play a 
vital role in viral or cellular mRNA maturation. A further investigation in this area is warranted.  
    Influenza continues to be a major public health burden. Viral protein NS1 is a major virulence factor 
and contributes significantly to the pathogenesis of influenza A viruses. Our results should be valuable for 
understanding the novel aspects of the host-influenza A virus interactions and may shed light on 
designing new drugs for preventing or treating influenza virus infection. 
 
